Imaging Anatomy {#s0010}
===============

Gross lung anatomy {#s0015}
------------------

### Segmental anatomy ([Figs. 1-1](#f0010){ref-type="fig"} and [1-2](#f0015){ref-type="fig"}) {#s0020}

#### Right Lung {#s0025}

Upper lobeApicalB1AnteriorB2PosteriorB3Middle lobeLateralB4MedialB5Lower lobeSuperiorB6Medial basalB7Anterior basalB8Lateral basalB9Posterior basalB10 Figure 1-1Figure 1-2

#### Left Lung {#s0030}

Upper lobe UpperApicoposteriorB1, 3AnteriorB2 LingulaSuperiorB4InferiorB5Lower lobeSuperiorB6Medial basalB7Anterior basalB8Lateral basalB9Posterior basalB10

### Segmental CT anatomy ([Fig. 1-3](#f0020){ref-type="fig"}) {#s0035}

Figure 1-3

### Bronchial CT anatomy ([Fig. 1-4](#f0025){ref-type="fig"}) {#s0040}

Figure 1-4

### Plain film anatomic landmarks ([Figure 1-5](#f0030){ref-type="fig"}, [Figure 1-6](#f0035){ref-type="fig"}, [Figure 1-7](#f0040){ref-type="fig"}, [Figure 1-8](#f0045){ref-type="fig"}, [Figure 1-9](#f0050){ref-type="fig"}) {#s0045}

#### Lines {#s0050}

•Anterior junction line: 2-mm linear line that projects over the trachea. Represents the anterior right and left pleura.•Posterior junction line: extends above clavicles•Azygoesophageal line: interface between RLL air and mediastinum•Left paraspinal line: extends from aortic arch to diaphragm•Right paraspinal line Figure 1-5Figure 1-6Figure 1-7Figure 1-8Figure 1-9

#### Paratracheal Stripe {#s0055}

•Abnormal if \>4 mm•Never extends below right bronchus

#### Fissures {#s0060}

•Minor (horizontal) fissure•Major (oblique) fissure•Azygos fissure•Other fissuresSuperior accessory lobeInferior accessory lobe

#### Upper Lobe Bronchi ([Figs. 1-10](#f0055){ref-type="fig"} and [1-11](#f0060){ref-type="fig"}) {#s0065}

•RUL bronchus always higher than LUL on lateral view•Posterior wall of bronchus intermedius (right) normally \<2 mm•Tracheal bronchus (bronchus suis): 0.1% of population, arises from right wall of trachea (left much less common), supplies apical segment or occasionally entire right upper lobe•Accessory cardiac bronchus: 0.1% of population, extends inferomedially from medial wall of bronchus intermedius or RLL bronchus toward mediastinum; may be blind ending Figure 1-10Figure 1-11

Parenchymal anatomy {#s0070}
-------------------

### Acinus {#s0075}

•Includes all structures distal to one terminal bronchiole. The terminal bronchiole is the last purely air-conducting structure.•Acinus measures 7 mm•Acinus contains about 400 alveoli

### Secondary pulmonary lobule {#s0080}

•Polygonal structure, 1.5 to 2 cm in diameter•Three to five acini per secondary lobule•Supplied by several terminal bronchioles

### Epithelium {#s0085}

The alveolar epithelium is made up of two cell types:•Type 1 pneumocytes•Type 2 pneumocytes: produce surfactant, have phagocytic ability, and regenerate

### High-resolution computed tomography (HRCT) ([Fig. 1-12](#f0065){ref-type="fig"}) {#s0090}

#### Technique {#s0095}

•1- to 1.5-mm thin collimation•High spatial frequency reconstruction•OptionalIncrease in kVp or mA (140 kVp, 170 mA)Targeted image reconstruction (one lung rather than both to improve spatial resolution) Figure 1-12

#### HRCT Anatomy {#s0100}

The basic pulmonary unit visible by HRCT represents the secondary pulmonary lobule:•Polyhedral 1.5-cm structure surrounded by connective tissue (interlobular septa)•Central artery and bronchiole•Peripheral pulmonary veins and lymphatics in septum

Pulmonary function ([Fig. 1-13](#f0070){ref-type="fig"}) {#s0105}
--------------------------------------------------------

### Lung volumes, capacities, and flow rates {#s0110}

•Tidal volume (TV): normal respiratory cycleFigure 1-13•Vital capacity (VC): amount of air that can be expired with force after maximal inspiration•Functional residual capacity (FRC): volume remaining in lung after quiet expiration•Total lung capacity (TLC): volume contained in lung at maximum inspiration•Forced expiratory volume (FEV): amount of air expired during 1 second (FEV~1~)

Mediastinum ([Fig. 1-14](#f0075){ref-type="fig"}) {#s0115}
-------------------------------------------------

•Superior mediastinum: plane above aortic arch; thoracic inlet structures•Anterior mediastinum: contains thymus, lymph nodes, mesenchymal tissue; some classifications include the heart•Middle mediastinum: contains heart, major vessels, bronchi, lymph nodes, and phrenic nerve•Posterior mediastinum: starts at anterior margin of vertebral bodies; contains descending aorta, esophagus, thoracic duct, lymph nodes, nerves, and paravertebral areas Figure 1-14

Imaging protocols {#s0120}
-----------------

### Standard chest ct protocol {#s0125}

Supine position. Scan in suspended inspiration at total lung capacity. Scan setup:•5- × 5-mm sections from apex of the lungs to the adrenals•Six 1.25-mm high-resolution cuts throughout lung at 2.5-cm intervals•1-mm reconstructions through pulmonary nodules•Number of different combinations of pitch and section thickness

In interstitial lung disease, the six cuts are repeated in prone position. Reconstruction is done with high-resolution bone algorithm.Use of IV contrast:•Evaluation of vascular structures, AVM, aortic dissection•Evaluation of mediastinal tumors, enlarged lymph nodes•Hilar masses•Neck masses

### Pulmonary embolism CT protocol {#s0130}

•Patient in supine position•Scan range: adrenals to lung apex•Injection of 140 mL of nonionic iodinated contrast at 3 mL/sec, with delay of 25 to 30 seconds. Scanning is performed with suspended respiration.•Scans are retrospectively reconstructed from the dome of the diaphragm as 2.5-mm thick slices with 1-mm spacing.

### Diagnostic radiology report (ACR) {#s0135}

An authenticated written interpretation should be performed on all radiologic procedures. The report should include the following items:1.Name of patient and other identifier (e.g., birth date, Social Security number, or hospital or office identification number)2.Name of the referring physician to provide more accurate routing of the report to one or more locations specified by the referring physician (e.g., hospital, office, clinic)3.History4.Name or type of examination5.Dates of the examination and transcription6.Time of the examination (for ICU/CCU patients) to identify multiple examinations (e.g., chest) that may be performed on a single day7.Body of the report:•Procedures and materialsInclude in the report a description of the procedures performed and any contrast media (agent, concentration, volume and reaction, if any), medications, catheters, and devices.•FindingsUse precise anatomic and radiologic terminology to describe the findings accurately.•LimitationsWhere appropriate, identify factors that can limit the sensitivity and specificity of the examination. Such factors might include technical factors, patient anatomy, limitations of the technique, incomplete bowel preparation, and wrist examination for carpal scaphoid.•Clinical issuesThe report should address or answer any pertinent clinical issues raised in the request for the imaging examination. For example, to rule out pneumothorax state "There is no evidence of pneumothorax"; or to rule out fracture, "There is no evidence of fracture." It is not advisable to use such universal disclaimers as "The mammography examination does not exclude the possibility of cancer."•Comparative dataComparisons with previous examinations and reports when possible are a part of the radiologic consultation and report and optionally may be part of the "impression" section.8.Impression (conclusion or diagnosis)•Each examination should contain an "impression" section.•Give a precise diagnosis whenever possible.•Give a differential diagnosis when appropriate.•Recommend, only when appropriate, follow-up and additional diagnostic radiologic studies to clarify or confirm the impression.

Infection {#s0140}
=========

General {#s0145}
-------

### Pathogens {#s0150}

Bacterial pneumonia•*Streptococcus pneumoniae* (pneumococcus)•*Staphylococcus*•*Pseudomonas*•*Klebsiella*•*Nocardia*•*Chlamydia*•*Neisseria meningitides*•*Haemophilus influenzae*•Anaerobes•*Legionella*•*Mycoplasma pneumoniae*•*Actinomyces israelii*•*Mycobacterium tuberculosis*Viral pneumonia (25% of community-acquired pneumonias)•Influenza•Varicella, herpes zoster•Rubeola•Cytomegalovirus (CMV)•Coxsackievirus, parainfluenza virus, adenovirus, respiratory syncytial virus (RSV)Fungal pneumonia•Histoplasmosis•Coccidioidomycosis•Blastomycosis•Aspergillosis•Cryptococcosis•Candidiasis•ZygomycosesParasitic pneumonias•*Pneumocystis jiroveci* Frenkel 1999 (formerly *Pneumocystis carinii)*•*Toxoplasma gondii*

### Acquisition of pneumonia {#s0155}

Community-acquired pneumonia•*S. pneumoniae, Haemophilus*•*Mycoplasma*Hospital-acquired pneumonia (incidence 1%, mortality 35%): nosocomial infection•Gram negatives: *Pseudomonas, Proteus, Escherichia coli, Enterobacter, Klebsiella*•Methicillin-resistant *Staphylococcus aureus* (MRSA)•Vancomycin-resistant enterococcus (VRE)Pneumonia in immunosuppressed patients•Bacterial pneumonia (gram negative) still most common•Tuberculosis•Fungal•*Pneumocystis* pneumonia (PCP)Endemic pneumonias•Fungal: histoplasmosis, coccidioidomycosis, blastomycosis•ViralAspiration-associated pneumonia (important)

### Risk factors {#s0160}

The radiographic appearance of pulmonary infections is variable depending on pathogen, underlying lung disease, risk factors, and prior or partial treatment.Community-Acquired InfectionsRisk FactorCommon PathogensAlcoholismGram negatives, *Streptococcus pneumoniae, M. tuberculosis*, aspiration (mouth flora)Old age*S. pneumoniae, Staphylococcus aureus*, aspirationAspirationMouth flora (anaerobes)Cystic fibrosis*Pseudomonas, S. aureus, Aspergillus*Chronic bronchitis*S. pneumoniae, H. influenzae* Other risk factors for developing pneumonia:•Bronchiectasis•Coma, anesthesia, seizures (aspiration)•Tracheotomy•Antibiotic treatment•Immunosuppression (renal failure, diabetes, cancer, steroids, AIDS)•Chronic furunculosis *(Staphylococcus)*

### Radiographic spectrum of pulmonary infections {#s0165}

SummaryTypePathogenImagingLobar PneumoniaInfection primarily involves alveoli\
Spread through pores of Kohn and canals of Lambert throughout a segment and ultimately an entire lobe\
Bronchi are not primarily affected and remain air-filled; therefore:\
  Air bronchograms\
  No volume loss because airways are open\
Nowadays uncommon due to early treatment\
Round pneumonia (children): *S. pneumoniaeS. pneumoniae*\
*K. pneumoniae*\
Others\
 *S. aureus*\
 *H. influenzae*\
  Fungal![](u01-01a-9780323065382.gif)\
![](u01-01b-9780323065382.gif)TypePathogenImagingBronchopneumoniaPrimarily affects the bronchi and adjacent alveoli\
Volume loss may be present as bronchi fill with exudate\
Bronchial spread results in multifocal patchy opacities*S. aureus*\
Gram negatives\
Others\
  *H. influenzae Mycoplasma*![](u01-02-9780323065382.gif)NodulesVariable in size\
Indistinct marginsFungal\
  *Histoplasma*\
  *Aspergillus*\
  *Cryptococcus*\
  *Coccidioides*\
Bacterial\
  *Legionella*\
  *Nocardia*\
Septic emboli\
  *S. aureus*![](u01-03-9780323065382.gif)Cavitary LesionsAbscess: necrosis of lung parenchyma ± bronchial communication\
Fungus ball (air crescent sign)\
Pneumatoceles due to air leak into pulmonary interstitium *(S. aureus)*Anaerobes\
Fungal\
TB![](u01-04-9780323065382.gif)Diffuse OpacitiesReticulonodular pattern: interstitial peribronchial areas of inflammation (viral)\
Alveolar location (PCP)\
Miliary pattern: hematogenous spread (TB)Viral\
*Mycoplasma*\
PCP![](u01-05-9780323065382.gif)

#### Complications of Pneumonia {#s0170}

•Parapneumonic effusionStage 1: exudation: free flowingStage 2: fibropurulent: loculatedStage 3: organization, erosion into lung or chest wall•Empyema•Bronchopleural fistula (fistula between bronchus and pleural space) with eroding pleural-based fluid collections•Bronchiectasis•Pulmonary fibrosis, especially after necrotizing pneumonia or acute respiratory distress syndrome (ARDS)•Adenopathy

### Resolution of pneumonia {#s0175}

•80%-90% resolve within 4 weeks•5%-10% resolve within 4 to 8 weeks (usually in older or diabetic patients). Subsequent films should always show interval improvement compared with the prior films.•NonclearanceAntibiotic resistanceConsider other pathogen (e.g., *M. tuberculosis*)Recurrent infectionObstruction pneumonitis due to tumor

Bacterial infections {#s0180}
--------------------

### General {#s0185}

#### Common Pathogens {#s0190}

•*S. pneumoniae*, 50% (40 to 60 years)•*Mycoplasma*, 30%•Anaerobes, 10%•Gram negatives, 5%•*Staphylococcus*, 5%•*Haemophilus*, 3% (especially in infants and patients with COPD)

#### Clinical Findings {#s0195}

Pneumonic syndrome•Fever•Cough•Pleuritic pain•SputumAncillary findings•Headache, arthralgia, myalgia•Diarrhea•Hemoptysis

### Streptococcal pneumonia {#s0200}

#### Radiographic Features {#s0205}

•Lobar or segmental pneumonia pattern•Bronchopneumonia pattern•Round pneumonia (in children)

### Staphylococcal pneumonia ([Fig. 1-15](#f0080){ref-type="fig"}) {#s0210}

#### Radiographic Features {#s0215}

•Bronchopneumonia pattern•Bilateral, \>60%•Abscess cavities, 25%-75%•Pleural effusion, empyema, 50%•Pneumatoceles, 50% (check valve obstruction), particularly in children•Central lines•Signs of endocarditis Figure 1-15

### *Pseudomonas* pneumonia {#s0220}

#### Typical Clinical Setting {#s0225}

•Hospital-acquired infection•Ventilated patient•Reduced host resistance•Patients with cystic fibrosis

#### Radiographic Features {#s0230}

Three presentations:•Extensive bilateral parenchymal consolidation (predilection for both lower lobes)•Abscess formation•Diffuse nodular disease (bacteremia with hematogenous spread; rare)

### Legionnaires\' disease {#s0235}

Severe pulmonary infection caused by *Legionella pneumophila;* 35% require ventilation, 20% mortality. Most infections are community acquired. Patients have hyponatremia. Seroconversion for diagnosis takes 2 weeks.

#### Radiographic Features {#s0240}

Common features•Initial presentation of peripheral patchy consolidation•Bilateral severe disease•Rapidly progressive•Pleural effusions, \<50%•Lower lobe predilectionUncommon features•Abscess formation•Lymph node enlargement

### *Haemophilus* pneumonia {#s0245}

Caused by *Haemophilus influenzae*. Occurs most commonly in children, immunocompromised adults, or patients with COPD. Often there is concomitant meningitis, epiglottitis, and bronchitis.

#### Radiographic Features {#s0250}

•Bronchopneumonia pattern•Lower lobe predilection, often diffuse•Empyema

### *Mycoplasma* pneumonia {#s0255}

Most common nonbacterial pneumonia (atypical pneumonia). Mild course. Age 5 to 20 years. Positive cold agglutinins, 60%.

#### Radiographic Features {#s0260}

•Reticular pattern•Lower lobe predominance, often diffuse•Consolidation, 50%

#### Complications {#s0265}

•Autoimmune hemolytic anemia•Erythema nodosum, erythema multiforme•Stevens-Johnson syndrome•Meningoencephalitis

### *Klebsiella* (friedländer) pneumonia {#s0270}

Gram-negative organism. Often in debilitated patients and/or alcoholics.

#### Radiographic Features {#s0275}

•Consolidation appears similar to that of infection with *S. pneumoniae*•Lobar expansion•Cavitation, 30%-50%, typically multiple•Massive necrosis (pulmonary gangrene)•Pleural effusion uncommon

### Tuberculosis (TB) ([Fig. 1-16](#f0085){ref-type="fig"}) {#s0280}

Transmitted by inhalation of infected droplets of *Mycobacterium tuberculosis* or *M. bovis*. TB usually requires constant or repeated contact with sputum-positive patients because the tubercle does not easily grow in the immunocompetent human host. Target population includes:•Patients of low socioeconomic scale (homeless)•Alcoholics•Immigrants: Mexico, Philippines, Indochina, Haiti•Elderly patients•AIDS patients•Prisoners Figure 1-16

#### Primary Infection ([Fig. 1-17](#f0090){ref-type="fig"}) {#s0285}

Usually heals without complications. Sequence of events includes:•Pulmonary consolidation (1 to 7 cm); cavitation is rare; lower lobe (60%) \> upper lobes•Caseous necrosis 2 to 10 weeks after infection•Lymphadenopathy (hilar and paratracheal), 95%•Pleural effusion, 10%•Spread of a primary focus occurs primarily in children or immunosuppressed patients Figure 1-17

#### Secondary Infection ([Fig. 1-18](#f0095){ref-type="fig"}) {#s0290}

Active disease in adults most commonly represents reactivation of a primary focus. However, primary disease is now also common in adults in developed countries because there is no exposure in childhood. Distribution is as follows:•Typically limited to apical and posterior segments of upper lobes or superior segments of lower lobes (because high Po~2~?)•Rarely in anterior segments of upper lobes (in contradistinction to histoplasmosis) Figure 1-18

#### Radiographic Features {#s0295}

•Exudative tuberculosisPatchy or confluent airspace diseaseAdenopathy uncommon•Fibrocalcific tuberculosisSharply circumscribed linear densities radiating to hilum•Cavitation, 40%

#### Complications ([Fig. 1-19](#f0100){ref-type="fig"}) {#s0300}

•Miliary TB may occur after primary or secondary hematogenous spread.•Bronchogenic spread occurs after communication of the necrotic area with a bronchus; it produces an acinar pattern (irregular nodules approximately 5 mm in diameter).•Tuberculoma (1 to 7 cm): nodule during primary or secondary TB; may contain calcification•Effusions are often loculated.•Bronchopleural fistula•Pneumothorax ComparisonPrimary TBReinfection TBLocationUsually basesUpper lobes, superior segmentLLAppearanceFocalPatchyCavitationNoFrequentAdenopathy as only findingCommonNoEffusionCommonUncommonMiliary patternYesYes Figure 1-19

### Nontuberculous mycobacterial (NTMB) infections {#s0305}

The two most common NTMB pathogens are *M. avium-intracellulare* and *M. kansasii* (less common: *M. xenopi, M. chelonei, M. gordonae, M. fortuitum =* "fast grower"). Unlike TB, NTMB infections are not acquired by human-human transmission but are a direct infection from soil or water. There is also no pattern of primary disease or reactivation: the infection is primary, although some may become chronic. The infection often occurs in elderly patients with COPD, older women in good health, and AIDS patients.

#### Radiographic Features {#s0310}

•NTMB infections may be indistinguishable from classic TB.•Atypical features such as bronchiectasis and bronchial wall thickening are common.•Nodules are common in older women. CT FindingsFindingsTB (%)MAI %Nodules \<1 cm8095Nodules 1-3 cm4030Mass \>3 cm1010Consolidation5050Cavity3030Bronchiectasis3095Bronchial wall thickening4095Septal thickening5015Emphysema2020Calcified granuloma155

### *Nocardia* pneumonia {#s0315}

Caused by *Nocardia asteroides,* worldwide distribution. Common opportunistic invader in:•Lymphoma•Steroid therapy; especially transplant patients•Pulmonary alveolar proteinosis (common)

#### Radiographic Features {#s0320}

•Focal consolidation (more common)•Cavitation•Irregular nodules

### Actinomycosis {#s0325}

Actinomycosis is caused by *Actinomyces israelii,* a gram-positive normal saprophyte in oral cavity. Pulmonary disease develops from aspiration of organism (poor dentition) or from direct penetration into the thorax.

#### Radiographic Features {#s0330}

•Focal consolidation \> cavitating mass•Lymphadenopathy uncommon•Extension into the chest wall and pleural thickening is less common today but still occurs and represents an important differential feature.

### Pulmonary abscess {#s0335}

The spectrum of anaerobic pulmonary infections includes:•Abscess: single or multiple cavities \>2 cm, usually with air-fluid level•Necrotizing pneumonia: analogous to abscess but more diffuse and cavities \<2 cm•Empyema: suppurative infection of the pleural space, most commonly as a result of pneumonia

#### Predisposing Conditions {#s0340}

•Aspiration (e.g., alcoholism, neurologic disease, coma)•Intubation•Bronchiectasis, bronchial obstruction

#### Treatment {#s0345}

•Antibiotics, postural drainage•Percutaneous drainage of empyema•Drainage/resection of lung abscess only if medical therapy fails

### Sickle cell anemia {#s0350}

•Patients with sickle cell disease are at increased risk of pneumonia and infarction. These entities are difficult to differentiate, hence called *acute chest syndrome.*•Pneumonias were originally due to pneumococci but now are due to viruses or *Mycoplasma.* Differential diagnosis includes atelectasis and infarct.•Infarcts more frequent in adults than in children. Rare in children under 12 years of age.•Consolidation is seen on chest films; resolves more slowly than in the general population, and tends to recur.

Viral pneumonia {#s0355}
---------------

### General {#s0360}

#### Classification {#s0365}

DNA virusesUnenveloped•Parvoviruses•Papovaviruses•Adenoviruses•Hepatitis viruses (hepatitis B)Enveloped•Herpesviruses (herpes simplex, Epstein-Barr, varicella zoster, CMV)•Poxviruses (variola, molluscum contagiosum)RNA virusesUnenveloped•Picornaviruses (hepatitis A, coxsackievirus)•Caliciviruses•ReovirusesEnveloped•Retroviruses (HIV)•Arenaviruses•Coronaviruses•Togaviruses•Bunyaviruses•Orthomyxoviruses (influenza)•Paramyxoviruses (mumps, measles, RSV, parainfluenza)

#### Occurrence {#s0370}

Immunocompetent hostsInfluenzaHantavirusEpstein-BarrAdenovirusImmunocompromised hostsHerpes simplexVaricella-zosterCytomegalovirusAdenovirus

#### Spectrum of Disease {#s0375}

•Acute interstitial pneumonia: diffuse or patchy interstitial pattern, thickening of bronchi, thickened interlobar septa•Lobular inflammatory reaction: multiple nodular opacities 5 to 6 mm (varicella; late calcification)•Hemorrhagic pulmonary edema: mimics bacterial lobar pneumonia•Pleural effusion: usually absent or small•Chronic interstitial fibrosis (bronchiolitis obliterans) VirusCentrilobular NodulesLobar Ground-glassDiffuse Ground-glassThickened Interlobular SeptaConsolidationInfluenza++++++++Epstein-Barr++++CMV++++++++Varicella-zoster+++++Herpes simplex++++++++Measles+++++Hantavirus++++++Adenovirus++++++

### Influenza pneumonia {#s0380}

Influenza is very contagious and thus occurs in epidemics. Pneumonia, however, is uncommon.

#### Radiographic Features {#s0385}

•Acute phase: multiple acinar densities•Coalescence of acinar densities to diffuse patchy airspace disease (bronchopneumonia type)

### Varicella zoster pneumonia {#s0390}

Fifteen percent of infected patients have pneumonias; 90% are older than 20 years.

#### Radiographic Features {#s0395}

•Acute phase: multiple acinar opacities•Coalescence of acinar opacities to diffuse patchy airspace disease•1- to 2-mm calcifications throughout lungs after healing

### CMV pneumonia {#s0400}

Occurs most commonly in neonates or immunosuppressed patients.

#### Radiographic Features {#s0405}

•Predominantly interstitial infection, multiple small nodules (common)•Adenopathy may be present

### Swine-origin influenza a (H1N1) virus (S-OIV) infection {#s0410}

Epidemiologic data to date suggest that the newly emerged H1N1 virus, although transmissible from person to person, is of relatively low virulence. Chest radiographs are normal in more than half of patients. However, the disease can progress to bilateral extensive airspace disease in severely ill patients. These patients are also at a high risk for PE, which should be sought carefully on contrast enhanced CT scans.

Fungal infections {#s0415}
-----------------

### General {#s0420}

Two broad categories:Endemic human mycoses (prevalent only in certain geographic areas):•Histoplasmosis (Ohio, Mississippi, St. Lawrence River valleys)•Coccidioidomycosis (San Joaquin Valley)•BlastomycosisOpportunistic mycoses (worldwide in distribution) occur primarily in immunocompromised patients (aspergillosis and cryptococcosis may also occur in immunocompetent hosts).•Aspergillosis•Candidiasis•Cryptococcosis•Mucormycosis

#### Radiographic Features {#s0425}

•Acute phase: pneumonic type of opacity (may be segmental, nonsegmental, or patchy); miliary (hematogenous) distribution in immunosuppressed patients•Reparative phase: nodular lesions with or without cavitations and crescent sign•Chronic phase: calcified lymph nodes or pulmonary focus with fungus (e.g., histoplasmosis)•Disseminated disease (spread to other organs) occurs primarily in immunocompromised patients

### Histoplasmosis ([Fig. 1-20](#f0105){ref-type="fig"}) {#s0430}

*Histoplasma capsulatum* is particularly prevalent in the Ohio, Mississippi, and St. Lawrence River valleys, although the agent is worldwide in distribution. The organism is most prevalent in soil that contains excrement of bats and birds (bat caves, chicken houses, old attics, or buildings).Figure 1-20

#### Clinical Findings {#s0435}

Most patients are asymptomatic or have nonspecific respiratory symptoms, increased complement fixation titer, and positive *H. capsulatum* antigen.

#### Radiographic Features {#s0440}

Consolidation (primary histoplasmosis)•Parenchymal consolidation•Adenopathy is very common and may calcify heavily later on.Nodular form (chronic histoplasmosis, reinfection)•Histoplasmoma: usually solitary, sharply circumscribed nodule, most commonly in lower lobes•Fibrocavitary disease in upper lobes indistinguishable from postprimary TB•Cavitary nodulesDisseminated form (immunocompromised patients)•Miliary nodules•Calcifications in liver and spleen

#### Mediastinal Histoplasmosis {#s0445}

Mediastinal histoplasmosis may follow pulmonary histoplasmosis. Two distinct entities (which may not always be separable from each other):Mediastinal granuloma•Results from spread of *H. capsulatum* to lymph nodes•Granulomas usually calcifiedMediastinal fibrosis (fibrosing mediastinitis)•May cause superior vena cava syndrome, airway compression, PA occlusion, pericarditis•Diffuse infiltration of mediastinum•Multiple densely calcified nodes

### Coccidioidomycosis ([Fig. 1-21](#f0110){ref-type="fig"}) {#s0450}

*Coccidioides immitis* is endemic in the southwest United States (San Joaquin Valley, "valley fever") and in Central and South America. Infection occurs due to inhalation of spores in soil. Human-to-human infection does not occur.Figure 1-21

#### Clinical Findings {#s0455}

Cutaneous manifestations common; 70% are asymptomatic.

#### Radiographic Features {#s0460}

Consolidation (primary form)•"Fleeting" parenchymal consolidation, most commonly lower lobes•Adenopathy in 20%Nodular form (chronic form, 5%)•15% cavitate50% have thin-walled cavity (suggestive of diagnosis)50% have thick-walled cavity (i.e., nonspecific)May present with pneumothorax•Nodules rarely calcify.•Hilar or paratracheal adenopathyDisseminated form (immunocompromised patients; rare: 0.5% of all forms)•Miliary nodules•Extrapulmonary spread

### North american blastomycosis ([Fig. 1-22](#f0115){ref-type="fig"}) {#s0465}

•Caused by *Blastomyces dermatitidis;* uncommon infection. Most infections are self-limited.•CXR is nonspecific: airspace disease \> nodule (15% cavitate) or solitary mass \> miliary spread.•Focal blastomycosis typically occurs in paramediastinal location and has an air bronchogram, findings that may suggest the diagnosis.•Satellite nodules around primary focus are common.•Adenopathy, pleural effusions, and calcifications are very uncommon.•Bone lesions, 25%•Skin lesions are common. Figure 1-22

### Aspergillosis ([Fig. 1-23](#f0120){ref-type="fig"}) {#s0470}

*Aspergillus* is a ubiquitous fungus that, when inhaled, leads to significant lung damage. The fungus grows in soil, water, decaying vegetation, and hospital air vents. Infection with *A. fumigatus \> A. flavus, A. niger,* or *A. glaucus.* There are four unique forms of pulmonary aspergillosis, each associated with a specific immune status.Types of AspergillosisTypeLung StructureImmune StatusPathologyAllergic (ABPA)NormalHypersensitivityHypersensitivity → bronchiectasis, mucus pluggingAspergillomaPreexisting cavityNormalSaprophytic growth in preexisting cavityInvasiveNormalSeverely impairedVascular invasion, parenchymal necrosisSemi-invasiveNormalNormal or impairedChronic local growth, local cavity formation Figure 1-23

### Allergic bronchopulmonary aspergillosis (ABPA) {#s0475}

ABPA represents a complex hypersensitivity reaction (type 1) to *Aspergillus,* occurring almost exclusively in patients with asthma and occasionally cystic fibrosis. The hypersensitivity initially causes bronchospasm and bronchial wall edema (IgE mediated); ultimately there is bronchial wall damage, bronchiectasis, and pulmonary fibrosis.

#### Clinical Findings {#s0480}

Elevated *Aspergillus-*specific IgE, elevated precipitating IgG against *Aspergillus,* peripheral eosinophilia, positive skin test. Treatment is with oral prednisone.

#### Radiographic Features {#s0485}

•Fleeting pulmonary alveolar opacities (common manifestation)•Central, upper lobe saccular bronchiectasis (hallmark) ([Fig. 1-24A](#f0125){ref-type="fig"} )Figure 1-24•Mucus plugging ("finger-in-glove" appearance) ([Fig. 1-24B](#f0125){ref-type="fig"}) and bronchial wall thickening (common)•Chronic disease may progress to pulmonary fibrosis predominantly in upper lobe (end stage).•Cavitation, 10%

### Aspergilloma (mycetoma, fungus ball) {#s0490}

Represents a saprophytic infection in preexisting structural lung disease (cavitary or bulla from TB, end-stage sarcoid, emphysema). Commonly in upper lobes, solitary lesions. The fungus grows in the cavity, creating a "fungus ball" consisting of fungus, mucus, and inflammatory cells. Treatment is with surgical resection and intracavitary administration of amphotericin.

#### Radiographic Features {#s0495}

•Focal intracavitary mass (3 to 6 cm), typically in upper lobes•Air may surround the aspergilloma (Monod sign), mimicking the appearance of cavitation seen with invasive aspergillosis.•Small area of consolidation around cavity is typical.•Adjacent pleural thickening common•Fungus ball moves with changing position

### Invasive aspergillosis {#s0500}

Invasive aspergillosis has a high mortality (70%-90%) and occurs mainly in severely immunocompromised patients (bone marrow transplants, leukemia). The infection starts with endobronchial fungal proliferation and then leads to vascular invasion with thrombosis and infarction of lung ("angioinvasive infection"). Additional sites of infection (in 30%) are brain, liver, kidney, GI tract. Treatment is with systemic and/or intracavitary administration of amphotericin.

#### Radiographic Features ([Fig. 1-25](#f0130){ref-type="fig"}) {#s0505}

•Multiple pulmonary nodules, 40%•Nodules have a characteristic halo of ground-glass appearance (represents pulmonary hemorrhage)•Within 2 weeks, 50% of nodules undergo cavitation, which results in the air crescent sign. The appearance of the air crescent sign indicates the recovery phase (increased granulocytic response). Note that the air crescent sign may also be seen in TB, actinomycosis, mucormycosis, septic emboli, and tumors. Do not confuse the air crescent sign with the Monod sign (clinical history helps to differentiate).•Other manifestations:Peribronchial opacitiesFocal areas of consolidation Figure 1-25

### Semi-invasive aspergillosis {#s0510}

This form of aspergillosis occurs in mildly immunocompromised patients and has a pathophysiology similar to that of invasive aspergillosis except that the disease progresses more chronically over months (mortality: 30%). Risk factors include diabetes, alcoholism, pneumoconiosis, malnutrition, and COPD. Treatment is with systemic and/or intracavitary administration of amphotericin.

#### Radiographic Features {#s0515}

•Appearance similar to that of invasive aspergillosis•Cavitation occurs at 6 months after infection

### Cryptococcosis {#s0520}

Caused by *Cryptococcus neoformans,* which is worldwide in distribution and ubiquitous in soil and pigeon excreta. Infection occurs through inhalation of contaminated dust.

#### Clinical Findings {#s0525}

Common in patients with lymphoma, steroid therapy, diabetes, and AIDS.

#### Radiographic Features {#s0530}

•Most common findings in lung are pulmonary mass, multiple nodules, or segmental or lobar consolidation.•Cavitation, adenopathy, and effusions are rare.•Disseminated form: CNS, other organs

### Candidiasis {#s0535}

Caused by *Candida albicans* \> other *Candida* species.

#### Clinical Findings {#s0540}

Typically in patients with lymphoreticular malignancy; suspect pulmonary disease if associated with oral disease. Often there is disseminated fungemia.

#### Radiographic Features {#s0545}

•Plain film is nonspecific: opacities (lower lobe) \> nodules•Nodular disease in disseminated form•Pleural effusion, 25%•Cavitation and adenopathy are rare.

### Zygomycoses {#s0550}

Group of severe opportunistic mycoses caused by fungi of the Zygomycetes class:•Mucormycosis *(Mucor)*•*Rhizopus*•*Absidia*Zygomycoses usually have two major clinical manifestations:•Pulmonary mucormycosis•Rhinocerebral mucormycosis

Zygomycoses are uncommon infections and occur primarily in immunocompromised patients (leukemia, AIDS, chronic steroid use, diabetes).

#### Radiographic Features {#s0555}

•Radiographic features similar to those of invasive aspergillosis because of angioinvasive behavior of fungi

Aids {#s0560}
====

General {#s0565}
-------

Acquired immunodeficiency syndrome is caused by HTLV type III (human T-cell lymphotrophic virus = HIV \[human immunodeficiency virus\]). HIV-1 and HIV-2 viruses are single-stranded RNA viruses that bind to CD4 present on T lymphocytes (other cells: glial cells, lung monocytes, dendritic cells in lymph nodes). The viral RNA genome is copied into DNA with the help of reverse transcriptase and integrated into the host cellular DNA.

### Epidemiology {#s0570}

The U.S. Centers for Disease Control and Prevention (CDC) estimates that at the end of 2008, there were 682,668 people living with a diagnosis of HIV infection in the 50 states and five U.S.--dependent areas. However, the total number of people living with an HIV infection in the U.S. is thought to be more than 1 million. Groups at highest risk include:•Homosexual males, bisexual males, 60%•IV drug abusers (IVDAs), 25%•Recipients of blood products, 3%•Congenital from AIDS-positive mothers•Heterosexual females: most rapidly growing group due to partners who are IVDAsKnown routes of HIV transmission:•Blood and blood products•Sexual activity•In utero transmission•During delivery

### Clinical findings {#s0575}

•Lymphadenopathy•Opportunistic infections•Tumors: lymphoma, Kaposi sarcoma•Other manifestations:Lymphocytic interstitial pneumonia (LIP)Spontaneous pneumothorax (development of cystic spaces, interstitial fibrosis related to PCP)Septic emboli•Clinical findings supportive of AIDS: ([Fig. 1-26](#f0135){ref-type="fig"} )CD4 count \<200/mm^3^; the dysfunction of the immune system is inversely related to the CD4 count; PCP: CD4 \<200 cells/mm^3^, MAI: CD4 \<50 cells/mm^3^\>1 case of bacterial pneumonia per year Figure 1-26

#### Opportunistic Infections {#s0580}

•*Pneumocystis jiroveci* Frenkel 1999, 70%•Mycobacterial infection, 20%; CD4 counts often \<50 cells/mm^3^•Bacterial infection, 10% *(S. pneumoniae, Haemophilus)*•Fungal infection (\<5% of AIDS patients)•*Nocardia,* \<5%: cavitating pneumonia•CMV pneumonia (common at autopsy)

Chest {#s0585}
-----

### General {#s0590}

•50% of all AIDS patients have pulmonary manifestations of infection or tumor.•A normal CXR does not exclude the diagnosis of PCP.•CMV is common at autopsy but does not cause significant morbidity or mortality; CMV antibody titers are present in virtually all patients with AIDS.•Use of chest CT in AIDS patients:Symptomatic patient with normal CXR; however, patients will commonly first undergo induced sputum or bronchoscopy or be put on empirical treatment for PCP.To clarify confusing CXRWorkup of focal opacities, adenopathy, nodules

### Spectrum of chest manifestations ([Fig. 1-27](#f0140){ref-type="fig"}) {#s0595}

Nodules•Kaposi sarcoma (usually associated with skin lesions)•Septic infarcts (rapid size increase)•Fungal: *Cryptococcus, Aspergillus*Large opacity: consolidation, mass•Hemorrhage•NHL•Pneumonia•Linear or interstitial opacities•PCP•Atypical mycobacteria•Kaposi sarcomaLymphadenopathy•Mycobacterial infections•Kaposi sarcoma•Lymphoma•Reactive hyperplasia, rare in thoraxPleural effusion•Kaposi sarcoma•Mycobacterial, fungal infection•Pyogenic empyema Figure 1-27

#### PCP infection ([Figure 1-28](#f0145){ref-type="fig"}, [Figure 1-29](#f0150){ref-type="fig"}, [Figure 1-30](#f0155){ref-type="fig"}) {#s0600}

##### Radiographic Features {#s0605}

•Interstitial pattern, 80%CXR: bilateral perihilar or diffuseHRCT: ground-glass appearance, predominantly in upper lobe with cysts•Progression to diffuse consolidation within days•Normal CXR in the presence of pulmonary PCP infection, 10%•Multiple upper lobe air-filled cysts or pneumatoceles (10%) causing:PneumothoraxBronchopleural fistulas•Upper lobe PCP involvement is common, because aerosolized pentamidine may not get to upper lobes; upper lobe disease may mimic TB but the latter may have pleural effusions or lymphadenopathy, both of which are uncommon in PCP.•Atypical patterns, 5%Unilateral diseaseFocal lesions, cavitary nodules•PCP as a presenting manifestation of AIDS is decreasing because of effective prophylaxis. Figure 1-28Figure 1-29Figure 1-30

### Mycobacterial infection {#s0610}

*M. tuberculosis \> M. avium-intracellulare* (this pathogen usually causes extrathoracic disease). CD4 cell count usually \<50 cells/mm^3^.

#### Radiographic Features {#s0615}

•Hilar and mediastinal adenopathy commonNecrotic lymph nodes (TB) have a low attenuation center and only rim enhance with contrast.MTB is more commonly associated with necrosis from MAI.Adenopathy in Kaposi sarcoma or lymphoma enhances uniformly.•Pleural effusion•Other findings are similar to non-AIDS TB (upper lobe consolidations, cavitations)

### Fungal infections {#s0620}

Fungal infections in AIDS are uncommon (\<5% of patients).•Cryptococcosis (most common); 90% have CNS involvement.•Histoplasmosis: nodular or miliary pattern most common; 35% have normal CXR.•Coccidioidomycosis: diffuse interstitial pattern, thin-walled cavities

### Kaposi sarcoma ([Fig. 1-31](#f0160){ref-type="fig"}) {#s0625}

The most common tumors in AIDS are:•Kaposi sarcoma (15% of patients); incidence declining; M:F = 50:1.•Lymphoma (\<5% of patients)Pulmonary manifestations of Kaposi sarcoma (almost always preceded by cutaneous/visceral involvement):•Nodules1 to 3 cmSingle or multipleVirtually always associated with skin lesions•Coarse linear opacities emanating from hilum•Pleural effusions (serosanguineous), 40%•Adenopathy•Lymphangitic tumor spread Figure 1-31

### Aids-related lymphoma {#s0630}

Non-Hodgkin lymphoma (usually aggressive B-cell type) \> Hodgkin lymphoma.Poor prognosis. Spectrum includes:•Solitary or multiple pulmonary masses ± air bronchogram, 25%•AIDS-related lymphoma is typically an extranodal disease (CNS, GI tract, liver, bone marrow): adenopathy not very prominent.•Pleural effusions are common.

Neoplasm {#s0635}
========

General {#s0640}
-------

### Location {#s0645}

Chest neoplasms are best categorized by their primary location:•Lung tumors•Pleural tumors•Mediastinal tumors•Tumors of the airway•Chest wall tumors

### Classification of pulmonary neoplasm {#s0650}

Malignant tumors•Bronchogenic carcinoma•Lymphoma•Metastases•Sarcomas, rareLow-grade malignancies (previously bronchial adenoma)•Carcinoid, 90%•Adenoid cystic carcinoma (previously cylindroma, resembles salivary gland tumor), 6%•Mucoepidermoid carcinoma, 3%•Pleomorphic carcinoma, 1%Benign tumors, rare•Hamartoma•Papilloma•Leiomyoma•Hemangioma•Chemodectoma•Pulmonary blastoma•Chondroma•Multiple pulmonary fibroleiomyomas•Pseudolymphoma

### Percutaneovus biopsy {#s0655}

The true positive rate of percutaneous lung biopsy is 90%-95%. False-negative results are usually due to poor needle placement, necrotic tissue, and so on. Tumor seeding is extremely uncommon (1:20,000).Contraindications to biopsy are usually relative and include:•Severe COPD•Pulmonary hypertension•Coagulopathy•Contralateral pneumonectomy•Suspected echinococcal cysts

#### Technique {#s0660}

1.Fluoroscopic or CT localization of nodule2.Pass needle over superior border of rib to avoid intercostal vessels3.Avoid passing through fissures4.Coaxial needle system•20-gauge outer needle•22-gauge inner needle5.Cytopathologist should be present to determine if sample is adequate and diagnostic.6.Chest film after procedure to determine presence of pneumothorax

#### Complications {#s0665}

•Pneumothorax, 25%; 5%-10% require a chest tube (i.e., pneumothorax \>25% or if patient is symptomatic)•Hemoptysis, 3%

Bronchogenic carcinoma {#s0670}
----------------------

*Bronchogenic carcinoma* refers broadly to any carcinoma of the bronchus. However, the use of the term is usually restricted to the following entities:

### Classification {#s0675}

Adenocarcinoma (most common), 40%•Bronchoalveolar carcinoma (often PET negative)•Papillary adenocarcinoma•Acinar adenocarcinoma•Solid adenocarcinoma with mucus formationSquamous cell carcinoma, 30%•Spindle cell carcinomaSmall cell carcinoma, 15%•Oat cell•Intermediate cell type•Combined oat cell carcinomaLarge cell carcinoma, 1%•Giant cell carcinoma•Clear cell carcinomaAdenosquamous tumor

### Risk factors for bronchogenic carcinoma {#s0680}

•Smoking: 98% of male patients and 87% of female patients with lung cancer smoke; 10% of heavy smokers will develop lung cancer. The strongest relationship between smoking and cancer has been established for SCC, followed by adenocarcinoma; the least common association is for bronchoalveolar carcinoma.•Radiation, uranium miners•Asbestos exposure•Genetic predisposition (HLA-Bw44 associated?)

### Radiographic spectrum {#s0685}

#### Primary Signs of Malignancy ([Fig. 1-32](#f0165){ref-type="fig"}) {#s0690}

•Mass (\>6 cm) or nodule (\<6 cm) with spiculated, irregular borders•Unilateral enlargement of hilum: mediastinal widening, hilar prominence•CavitationMost common in upper lobes or superior segments of lower lobesWall thickness is indicative of malignancy.\<4 mm: 95% of cavitated lesions are benign.\>15 mm: 85% of cavitated lesions are malignant.Cavitation is most common in SCC.•Certain tumors may present as chronic airspace disease: bronchoalveolar carcinoma, lymphoma.•Some air bronchograms are commonly seen by HRCT in adenocarcinoma. Figure 1-32

#### Secondary Signs of Malignancy ([Fig. 1-33](#f0170){ref-type="fig"}) {#s0695}

•Atelectasis (Golden inverted "S" sign in RUL, LUL collapse)•Obstructive pneumonia•Pleural effusion•Interstitial patterns: lymphangitic tumor spread•Hilar and mediastinal adenopathy•Metastases to ipsilateral, contralateral lung Locations of TumorsTumorFrequencyLocationCommentsAdenocarcinoma40%PeripheralScar carcinomaSquamous cell carcinoma30%Central, peripheral[\*](#tf0010){ref-type="table-fn"}CavitationSmall cell carcinoma15%Central, peripheral[\*](#tf0010){ref-type="table-fn"}Endocrine activityLarge cell carcinoma1%Central, peripheralLarge mass[^1] Figure 1-33

### Paraneoplastic syndromes of lung cancer {#s0700}

Incidence: 2% of bronchogenic carcinomaMetabolic•Cushing syndrome (ACTH)•Inappropriate antidiuresis (ADH)•Carcinoid syndrome (serotonin, other vasoactive substances)•Hypercalcemia (PTH, bone metastases)•Hypoglycemia (insulin-like factor)Musculoskeletal•Neuromyopathies•Clubbing of fingers (HPO) Other•Acanthosis nigricans•Thrombophlebitis•Anemia

### Radiation pneumonitis {#s0705}

Radiation pneumonitis represents the acute phase of radiation damage and usually appears 3 weeks after treatment. Minimum radiation to induce pneumonitis is 30 Gy. The acute phase is typically asymptomatic but may be associated with fever and cough. Fibrosis usually occurs after 6 to 12 months.

#### Radiographic Features {#s0710}

•Diffuse opacities in radiation port•HRCT allows better assessment of extent than plain film.

Tumor staging ([Fig. 1-34](#f0175){ref-type="fig"}) {#s0715}
---------------------------------------------------

### TNM staging system, 7th edition (non--small cell lung cancer) {#s0720}

Primary tumor (T)T0 No evidence of a primary tumorT1 \<3 cm, limited to lung, not more proximal than lobar bronchusT1a ≤ 2 cmT1b \>2 and ≤ 3 cmT2 \>3 cm but ≤ 7 cm;•or invades parietal pleura•or involves main bronchus ≥ 2 cm distal to carina•or atelectasis/obstructive pneumonia extending to hilum but not involving entire lungT2a \>3 but ≤ 5 cmT2b \>5 but ≤ 7 cmT3 \>7 cm; •or directly invades chest wall, diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium•or mainstem bronchus \<2 cm distal to carina•or atelectasis/obstructive pneumonia involving entire lung•or separate tumor nodules in a different ipsilateral lobeT4 Heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, or carina; or separate tumor nodules in a different ipsilateral lobeNodes (N)N0 No lymph node involvementN1 Ipsilateral hilar nodesN2 Ipsilateral mediastinal or subcarinal nodesN3 Contralateral hilar or mediastinal nodes; supraclavicular nodesMetastases (M)M0 No metastasesM1 MetastasesM1a Separate tumor nodules in contralateral lobe; or pleural nodules or malignant pleural disseminationM1b Distant metastases Figure 1-34

#### Unresectable Stages {#s0725}

•Tumors are unresectable if T4, N3, or M1 (stage 3b or 4)•Stage 3b: N3, M0, any T; T4, M0, any N•Stage 4: M1, any T, any N

### 5-Year survival {#s0730}

Overall 5-year survival rate is 14%.Stage 1: 57%-67%Stage 2: 39%-55%Stage 3a (limited disease): 23%Stage 3b (T4): 7%Stage 3b (N3): 3%Stage 4: 1%

### Small cell cancer staging {#s0735}

Although the TNM system can also be used for small cell cancer, it is often not used because of the presence of metastasis at the time of diagnosis. Instead, a two-stage system is used: "limited" and "extensive." *Limited* stage means the cancer is confined to one lung with ipsilateral lymph node metastasis (can be encompassed by a single radiation port) and has better prognosis. *Extensive* stage means metastasis to contralateral lung and nodes or to distant organs (including the pleura). About two thirds of patients with small cell cancer are at the extensive stage at first diagnosis.

### Lymph node imaging {#s0740}

#### Anatomy ([Fig. 1-35](#f0180){ref-type="fig"}) {#s0745}

Anterior mediastinal nodes•Parietal node groupInternal mammary nodesSuperior diaphragmatic nodes•Prevascular node group (anterior to the great vessels)Middle mediastinal nodes•Paratracheal[\*](#fn0010){ref-type="fn"} ; the lowest node is the azygos node•Subcarinal[\*](#fn0010){ref-type="fn"}: below bifurcation; drainage to right paratracheal nodes•Subaortic; AP window node•Tracheobronchial (pulmonary root, hilar)Posterior mediastinal nodes•Paraaortic•Prevertebral•Paraspinous: lateral to vertebral body Figure 1-35

#### American Thoracic Society Classification ([Fig. 1-36](#f0185){ref-type="fig"}) {#s0750}

This classification system assigns numbers to regional lymph nodes:•2R, 2L: paratracheal•4R, 4L: superior tracheobronchial•5, 6: anterior mediastinal•7: subcarinal•8, 9: posterior mediastinal•10R, 10L: bronchopulmonary•11R, 11L: pulmonary•14: diaphragmatic Figure 1-36

#### CT Criterion for Abnormal Nodes {#s0755}

Short-axis lymph node diameter \>1 cm (60%-70% accuracy for differentiating between malignant and benign adenopathy)

### Chest wall invasion {#s0760}

Accuracy for detection of chest wall invasion by CT is 40%-60%.

#### Radiographic Features ([Fig. 1-37](#f0190){ref-type="fig"}) {#s0765}

Reliable signs•Soft tissue mass in chest wall•Bone destructionUnreliable signs•Obtuse angles at contact between tumor and pleura•\>3 cm of contact between tumor and pleura•Pleural thickening•Increased density of extrapleural fat Figure 1-37

### Mediastinal invasion {#s0770}

Contiguous invasion of mediastinal organs, heart, great vessels, aerodigestive tract, and vertebra indicates nonresectability.

#### Radiographic Features {#s0775}

•Diaphragmatic paralysis (phrenic nerve involvement)•Mediastinal mass with encasement of mediastinal structures•MRI may be useful to detect vascular invasion.

### Malignant pleural effusion {#s0780}

Development of pleural effusions usually indicates a poor prognosis. Presence of a documented malignant pleural effusion makes a tumor unresectable (M1). Incidence of pleural effusion:•Bronchogenic carcinoma, 50%•Metastases, 50%•Lymphoma, 15%

#### Pathogenesis of Malignant Effusions {#s0785}

•Pleural invasion increases capillary permeability.•Lymphatic or venous obstruction decreases clearance of pleural fluid.•Bronchial obstruction → atelectasis → decrease in intrapleural pressure.

### Central bronchial involvement {#s0790}

Tumors that involve a central bronchus usually cause lung collapse or consolidation. These tumors are considered unresectable (T4 tumors) only if they involve the carina.

### Metastases to other organs {#s0795}

Lung tumors most frequently metastasize to:Liver (common)Adrenal glands (common)•30% of adrenal masses in patients with adenocarcinoma are adenomas.•Most adrenal masses in patients with small cell carcinomas are metastases.•Tumor may be present in a morphologically normal-appearing gland.Other sites (especially small and large cell tumors)•Brain (common)•Bones•Kidney

Specific lung tumors {#s0800}
--------------------

### Adenocarcinoma {#s0805}

Now the most frequent primary lung cancer. Typically presents as a multilobulated, peripheral mass. May arise in scar tissue: scar carcinoma.

### Bronchioloalveolar carcinoma {#s0810}

Subtype of adenocarcinoma; slow growth. The characteristic radiographic presentations are:•Morphologic typeSmall peripheral nodule (solitary form), 25% (most common)Multiple nodulesChronic airspace disease•Air bronchogram•Absent adenopathy•Cavitation may be seen by HRCT (Cheerio sign)

### Squamous cell carcinoma (SCC) {#s0815}

SCC is most directly linked with smoking. SCC carries the most favorable prognosis. The most characteristic radiographic appearances are:•Cavitating lung mass, 30%•Peripheral nodule, 30%•Central obstructing lesion causing lobar collapse•Chest wall invasion

### Pancoast tumor (superior sulcus tumor) {#s0820}

Tumor located in the lung apex that has extended into the adjacent chest wall. Histologically, Pancoast tumors are often SCC.

#### Clinical Findings {#s0825}

•Horner syndrome•Pain radiating into arm (invasion of pleura, bone, brachial plexus, or subclavian vessels)

#### Radiographic Features ([Fig. 1-38](#f0195){ref-type="fig"}) {#s0830}

•Apical mass•Chest wall invasion•Involvement of subclavian vessels•Brachial plexus involvement•Bone involvement: rib, vertebral body Figure 1-38

### Small cell carcinoma (neuroendocrine tumor, type 3) {#s0835}

Most aggressive lung tumor with poor prognosis. At diagnosis, two thirds of patients already have extrathoracic spread:•Typical initial presentation: massive bilateral lymphadenopathy•With or without lobar collapse•Brain metastases

### Large cell carcinoma {#s0840}

Usually presents as large (\>70% are \>4 cm at initial diagnosis) peripheral mass lesions. Overall uncommon tumor.

### Carcinoid (neuroendocrine tumor, types 1 and 2) {#s0845}

Represent 90% of low-grade malignancy tumors of the lung. The 10-year survival with surgical treatment is 85%.

#### Types {#s0850}

•Typical carcinoid: local tumor (type 1)•Atypical carcinoid (10%-20%): metastasizes to regional lymph nodes (type 2); liver metastases are very rare.

#### Radiographic Features {#s0855}

PET negativeCentrally located carcinoid, 80%•Segmental or lobar collapse (most common finding)•Periodic exacerbation of atelectasis•Endobronchial massPeripherally located carcinoid, 20%•Pulmonary nodule•May enhance with contrast Comparison of Clinical, Pathologic, and Imaging Findings in Neuroendocrine Tumors of the LungFindingsTypical CarcinoidAtypical CarcinoidLCNECSCLCDemographic FeaturesMean patient age (yr)40-4950-5960-6970-79Association with smokingNoYesYesYesM:F ratio1:12:1\>2.5:1\>2.5:1Histopathologic FeaturesMitoses per 10 HPFs\<22-10\>10\>50NecrosisNoYesYesYesImaging FindingsCentral to peripheral ratio3:13:11:410-20:1Calcification or ossification30%30%9%Up to 23%Extrathoracic metastases15%15%35%60%-70%EnhancementHigh; central or rimHigh; central or rimHighHigh with necrosisFDG uptake at PETLowLowHighHigh[^2]

### Hamartoma ([Fig. 1-39](#f0200){ref-type="fig"}) {#s0860}

Hamartomas are the most common benign tumors of the lung composed of cartilage (predominant component), connective tissue, muscle, fat, and bone. 90% are peripheral, 10% are endobronchial.Figure 1-39

#### Radiographic Features {#s0865}

•Well-circumscribed solitary nodules•Chondroid "popcorn" calcification is diagnostic but uncommon (\<20%).•Fat attenuation within a lesion by HRCT is pathognomonic.

### Carney triad {#s0870}

#### Predominant in Young Women {#s0875}

•Gastric smooth muscle tumors (epithelioid leiomyosarcoma)•Functioning extraadrenal paraganglioma•Pulmonary chondroma

### Tracheobronchial papillomatosis {#s0880}

#### Radiographic Features {#s0885}

•Multiple, well demarcated nodules that can grow•Cavitate with 2 to 3 mm thick walls•Air fluid levels may develop•Risk of squamous cell carcinoma 15 years after diagnosis

### Pulmonary blastoma {#s0890}

#### Predominant in Males, Poor Prognosis {#s0895}

##### Radiographic Features {#s0900}

•Large peripheral mass that is well circumscribed•May show pleural invasion and may metastasize

Lung metastases from other primary lesions {#s0905}
------------------------------------------

### General {#s0910}

Pathways of metastatic spread from a primary extrathoracic site to lungs (in order of frequency):•Spread via pulmonary arteries•Lymphatic spread (celiac nodes → posterior mediastinal nodes + paraesophageal nodes) and in lung parenchyma•Direct extension•Endobronchial spreadNeoplasms with rich vascular supply draining into systemic venous system:•Renal cell carcinoma•Sarcomas•Trophoblastic tumors•Testis•ThyroidNeoplasms with lymphatic dissemination:•Breast (usually unilateral)•Stomach (usually bilateral)•Pancreas•Larynx•CervixOther neoplasms with high propensity to localize in lung:•Colon•Melanoma•Sarcoma

#### Radiographic Features {#s0915}

•Multiple lesions, 95% \> solitary lesion, 5%•Lung bases \> apices (related to blood flow)•Peripheral, 90% \> central, 10%•Metastases typically have sharp margins.•Fuzzy margins can result from peritumoral hemorrhage (choriocarcinoma, chemotherapy).•Cavitations are common in SCCs from head and neck primary lesions.

### Calcified metastases {#s0920}

Calcifications in lung metastases are observed in:Bone tumor metastases•Osteosarcoma•ChondrosarcomaMucinous tumors•Ovarian•Thyroid•Pancreas•Colon•StomachMetastases after chemotherapy

### Giant metastases ("cannon ball" metastases) in asymptomatic patient {#s0925}

•Head and neck cancer•Testicular and ovarian cancer•Soft tissue cancer•Breast cancer•Renal cancer•Colon cancer

### Sterile metastases {#s0930}

This term refers to pulmonary metastases under treatment that contain no viable tumor. Nodules typically consist of necrotic and/or fibrous tissue.

Chronic Lung Disease {#s0935}
====================

Idiopathic diseases {#s0940}
-------------------

Overview of Idiopathic Interstitial PneumoniasDiagnosisClinical FindingsHRCT FeaturesDifferential DiagnosisUIP/IPF40-70 years, M\>F; \>6 month dyspnea, cough, crackles, clubbing; poor response to steroidsPeripheral, basal, subpleural reticulation and honeycombing ± ground-glass opacityCollagen vascular disease, asbestosis, CHP, scleroderma, drugs (bleomycin, methotrexate)NSIP40-50 years, M = F; dyspnea, cough, fatigue, crackles; may respond to steroidsBilateral, patchy, subpleural ground-glass opacity, ± reticulationCollagen vascular disease, CHP, DIPRB-ILD30-50 years, M \> F; dyspnea, coughGround-glass, centrilobular nodules, ± centrilobular emphysemaHypersensitivity pneumonitisAIP/diffuse alveolar damageAny age, M = F; acute-onset dyspnea, diffuse crackles and consolidationGround-glass consolidation, traction bronchiectasis and architectural distortionARDS, infection, edema, hemorrhageCOPMean 55 years, M = F; \<3 month history of cough, dyspnea, fever; may respond to steroidsSubpleural and peribronchial consolidation ± nodules in lower zones; atoll sign (ring-shaped opacity)Collagen vascular disease, infection, vasculitis, sarcoidosis, lymphoma, alveolar carcinomaDIP30-54 years, M \> F; insidious onset weeks to months of dyspnea, coughGround-glass opacity, lower zone, peripheralHypersensitivity pneumonitis, NSIPLIPAny age, F \> MGround-glass opacity, ± poorly defined centrilobular nodules, thin-walled cysts and air trappingDIP, NSIP, hypersensitivity pneumonitis[^3]

### Usual interstitial pneumonia (UIP) {#s0945}

Multiple etiologies exist, which may produce a histologic pattern of UIP. Idiopathic pulmonary fibrosis (IPF) is the term used when no cause is identified; synonyms: cryptogenic fibrosing alveolitis (CFA, British term). Prognosis: mean survival 4 years (range 0.4 to 20 years). Lung biopsy is necessary for diagnosis. Treatment with steroids is useful in 50%, also cytotoxic agents.

#### Clinical Findings {#s0950}

•Clubbing, 60%•Nonproductive cough, 50%•Dyspnea•Weight loss, 40%

#### Pathology {#s0955}

Pathologic changes are nonspecific and also occur in a variety of secondary disorders such as collagen vascular disease, drug reactions, pneumoconiosis, chronic hypersensitivity pneumonitis. Histology demonstrates alveolar fibrosis characterized by spatial and temporal heterogeneity, with architectural distortion.

#### Radiographic Features ([Figs. 1-40](#f0205){ref-type="fig"} and [1-41](#f0210){ref-type="fig"}) {#s0960}

Distribution•IPF: Primarily in lower lung zones•Peripheral subpleural involvementHRCT pattern•Early: ground-glass appearance•Later: reticular pattern predominantly in lower lobes•End stage: honeycombing•Traction bronchiectasis indicates fibrosis.Other•Low lung volumes (fibrosis)•Pulmonary hypertension with cardiomegaly (fibrosis), 30%•Uncommon findingsPleural thickening, 5%Pneumothorax, 5%Effusion, 5% Figure 1-40Figure 1-41

### Sarcoid {#s0965}

The term *sarcoid* (sarcoma-like) was first coined by Caesar Boeck in 1899 to describe one of the skin lesions of sarcoidosis because of its histologic resemblance to a sarcoma. Systemic granulomatous disease of unknown etiology (lung, 90% \> skin, 25% \> eye, 20% \> hepatosplenomegaly, 15% \> CNS, 5% \> salivary glands \> joints \> heart). Treatment is with steroids.

#### Clinical Findings {#s0970}

Ten to 20 times more common in blacks than in whites, 30% are asymptomatic.

#### Prognosis {#s0975}

Adenopathy only: more benign course•75% regress to normal within 3 years•10% remain enlarged•15% progress to stages 2 and 3Parenchymal abnormalities: 20% develop progressive pulmonary fibrosis

#### Associations {#s0980}

•Löfgren syndrome: acute febrile illness with bilateral hilar adenopathy and erythema nodosum in a patient with sarcoid. May also have uveitis or parotitis and arthralgias of large joints. These findings are associated with a favorable prognosis.•Heerfordt syndrome: parotid gland enlargement, fever, uveitis, and cranial nerve palsies. The condition is usually self-limited and most commonly affects patients in the 2nd to 4th decades of life.•Lupus pernio: violaceous (blue-purple) raised skin lesions on the cheeks and nose in a patient with sarcoid. Prognosis is poor.•In HIV: A number of cases of new-onset sarcoid have been described in HIV patients after initiation of antiretroviral therapy with rise in CD4 count. This may be related to immune restoration. The radiologic features are similar to those of sarcoid in non-HIV patients.

#### Diagnosis {#s0985}

Biopsy•Bronchial and transbronchial biopsy (sensitivity 90%)•Open lung biopsy (sensitivity 100%)•Lymph node, parotid gland, or nasal mucosa biopsy (sensitivity 95%)•Mediastinoscopy (sensitivity 95%)Kveim test (sensitivity 70%-90%). Problems:•Unavailability of validated tissue suspension (made from splenic tissue of infected patients)•Lack of reactivity late in the disease•Delay of 4 to 6 weeks before reactivity occurs

#### Radiographic Features ([Figs. 1-42](#f0215){ref-type="fig"} and [1-43](#f0220){ref-type="fig"}) {#s0990}

Stages (Siltzbach classification, plain film):Stage 0: initial normal film, 10%Stage 1: adenopathy, 50%•Symmetrical hilar adenopathy•Paratracheal, tracheobronchial, and azygos adenopathy are commonly associated with hilar adenopathy (Garland triad).•Calcification, 5%Stage 2: adenopathy with pulmonary opacities, 30%•Reticulonodular pattern•Acinar pattern may coalesce to consolidation.•Large nodules \>1 cm (2%)Stage 3: pulmonary opacities without hilar adenopathy, 10%Stage 4: pulmonary fibrosis, upper lobes with bullaeOther less common plain film findings:•Pleural effusion, 10%•Unilateral hilar adenopathy, 1%-3%•Eggshell calcification of lymph nodes•Complications:Pneumothorax (blebs, bullae)*Aspergillus* with fungus ball: A complication of stage 4 disease. Pleural thickening may be the earliest indication of *Aspergillus* superinfection, occurring 2 to 3 years before appearance of an intracavitary fungus ball. The pleural thickening may achieve a thickness of 2 cm or more.*Cardiac arrhythmias:* Early initiation of steroid therapy can help to prevent these arrhythmias.Bronchostenosis with lobar/segmental collapse Figure 1-42Figure 1-43

#### CT Features {#s0995}

Lung parenchyma•Nodules (90%), along lymphatic distribution (i.e., central or axial and subpleural)•Linear pattern, 50%•Ground-glass opacity, 25%•Subpleural thickening, 25%•Pseudoalveolar consolidation, 15%Lymph nodes•Adenopathy, 80%Bronchi•Wall abnormalities, 65%•Luminal abnormalities, 25%•Bronchiectasis, 10%End stage•Upper lobe fibrosis•Bullae•Traction bronchiectasis

#### ^67^Ga Scintigraphic Findings {#s1000}

Accumulation of ^67^Ga is a sensitive but nonspecific indicator of active inflammation in patients with sarcoidosis. Gallium avidity cannot be used alone to establish a diagnosis of sarcoidosis. However, ^67^Ga imaging is useful in identifying extrathoracic sites of involvement, detecting active alveolitis, and assessing response to treatment.

Gallium uptake in thoracic lymph nodes, lungs, and salivary and lacrimal glands is particularly suggestive of sarcoidosis. How well the extent of gallium uptake in the lung correlates with the degree of alveolitis is controversial. However, ^67^Ga scans may be useful as a baseline study at the time of diagnosis. If results of ^67^Ga scintigraphy are initially positive, negative findings from a subsequent ^67^Ga scan obtained during the course of treatment suggest that alveolitis has resolved. In such a patient, gallium may be a useful marker for disease activity and response to therapy.

### Nonspecific interstitial pneumonia (NSIP) {#s1005}

Important to distinguish from UIP given a better response to steroids. Patients are typically younger than those with UIP and symptoms are milder. Associated with drug exposure hypersensitivity pneumonitis and collagen vascular disease.

#### Pathology {#s1010}

Histologically characterized by spatial and temporal homogeneity of interstitial inflammation with varying degrees of fibrosis. Limited fibrosis identifies the cellular NSIP subtype; however, the fibrotic NSIP subtype is more common.

#### HRCT Features {#s1015}

•Patchy ground-glass opacities, reticular opacities, micronodules•Subpleural, symmetric, without the basilar predominance seen in UIP•Honeycombing occasionally seen in fibrotic subtype

### Respiratory bronchiolitis-associated interstitial pneumonia (RB-ILD) {#s1020}

Smoking-related interstitial lung disease, representing a symptomatic form of the often incidentally detected respiratory bronchiolitis. Smoking cessation is key to treatment, although steroids may be helpful.

#### Pathology {#s1025}

Histologically characterized by respiratory bronchioles that are filled with macrophages.

#### HRCT Features {#s1030}

•Diffuse centrilobular nodules and ground-glass opacities•Bronchial wall thickening•Coexisting centrilobular emphysema may be noted

### Desquamative interstitial pneumonia (DIP) {#s1035}

Represents the most severe form of the continuum of smoking-related interstitial lung disease (RB, RB-ILD, DIP).

#### Pathology {#s1040}

Histologically characterized by alveolar spaces that are filled with macrophages.

#### HRCT Features {#s1045}

•Diffuse ground-glass opacities (versus centrilobular distribution in RB-ILD)•Peripheral and basilar predominance•Septal thickening•Occasional small cystic spaces

### Cryptogenic organizing pneumonia (COP) {#s1050}

Formerly termed bronchiolitis obliterans organizing pneumonia (BOOP). Histologic pattern may also be seen in collagen vascular disease, drug exposure, and infection. Patients present with cough, mild dyspnea, and fever over several months; there may be an antecedent history of respiratory infection.

#### Pathology {#s1055}

Intraalveolar proliferation of granulation tissue is seen, with temporal uniformity.

#### HRCT Features {#s1060}

•Patchy consolidation or ground-glass opacities•Subpleural, peribronchial, lower \> upper lung distribution•May also see small centrilobular nodules or large irregularly shaped masses•Atoll sign: crescent-shaped opacity

### Lymphoid interstitial pneumonia (LIP) {#s1065}

Women \> men, associated with Sjögren syndrome, SLE, HIV infection; rarely idiopathic. Common in pediatric AIDS patients. Variable response to steroids. May progress to lymphoma in \<20%. A localized form of LIP has been called "pseudolymphoma" because of histologic resemblance to lymphoma.

#### Pathology {#s1070}

Diffuse interstitial infiltrate composed of lymphocytes, plasma cells, and histiocytes.

#### HRCT Features {#s1075}

•Ground-glass opacities ± poorly defined centrilobular nodules•Basilar distribution or diffuse•Perivascular cysts•Late honeycombing

### Acute interstitial pneumonia (AIP) {#s1080}

Present with severe dyspnea requiring mechanical ventilation, usually several weeks after viral URI. Mortality, 50%. Men = women, supportive therapy although steroids may help. Formerly known as Hamman-Rich syndrome.

#### Pathology {#s1085}

Diffuse alveolar damage. Exudative phase demonstrates hyaline membranes and alveolar infiltration by lymphocytes. Progresses to organizing phase after 1 week, with alveolar wall thickening due to fibrosis.

#### HRCT Features {#s1090}

•Similar to ARDS, but often with a symmetric, posterior lower lobe distribution•Exudative phase: ground-glass opacities, consolidation•Organizing phase: architectural distortion, traction bronchiectasis, honeycombing

Lymphoproliferative disorders {#s1095}
-----------------------------

Spectrum of lymphoid abnormalities in the chest characterized by accumulation of lymphocytes and plasma cells in the pulmonary interstitium or mediastinal/hilar lymph nodes. Believed to be due to stimulation of bronchus-associated lymphoid tissue by antigens.

###  {#s1100}

#### Types {#s2890}

Nodal disorders•Castleman disease (see [Middle Mediastinal Tumors](#s2340){ref-type="sec"})•Infectious mononucleosis•Angioimmunoblastic lymphadenopathy: drug hypersensitivityPulmonary parenchymal disorders•Plasma cell granuloma (inflammatory pseudotumor, histiocytoma)•Pseudolymphoma•Lymphocytic interstitial pneumonia (LIP)•Lymphomatoid granulomatosis Overview of Lymphoproliferative DiseasesDiagnosisLungNodesEffusionMalignancyNodesCastleman diseaseUnaffectedYesNoNoInfectious mononucleosisMediastinal adenopathyYesNoNoAngioimmunoblastic lymphadenopathyInterstitial and alveolar opacityYes10%30%ParenchymalPlasma cell granulomaSolitary pulmonary massNoNoNoPseudolymphomaSingle or multiple parenchymal masses, air bronchogramsNoNo20%LIPBilateral interstitial diseaseNoNo\<20%Lymphomatoid granulomatosisMultiple pulmonary nodules, frequent cavitationRare35%30% Differentiation of Lymphoma and Lymphoproliferative DiseaseParameterLymphoproliferative DisorderLymphomaLocationParenchyma *or* lymph nodes but not bothParenchyma *and* lymph nodesLymphoid populationPolyclonalMonoclonalOnsetYoung patients (\<30 years)Old patients (\>50 years)PrognosisUsually benign or low-grade malignancyMalignant

### Plasma cell granuloma {#s1105}

Local cellular proliferation of spindle cells, plasma cells, lymphocytes, and histiocytes in lung. Most common tumor-like pulmonary abnormality in children \<15 years. Treatment is resection.

#### Radiographic Features ([Fig. 1-44](#f0225){ref-type="fig"}) {#s1110}

•Solitary lung mass 1 to 12 cm•No or very slow growth•Cavitation and calcification uncommon Figure 1-44

### Lymphangioleiomyomatosis (LAM) {#s1115}

Proliferation of smooth muscle cells along lymphatics in lung, thorax, and abdomen. Unknown etiology. Rare.

#### Clinical Findings {#s1120}

Young women presenting with spontaneous pneumothorax, chylothorax, hemoptysis, slowly progressive dyspnea. Ten-year survival 75%. Similar lesions may be seen in tuberous sclerosis (LAM has been dubbed a *forme fruste* of tuberous sclerosis).

Extrapulmonary LAM is rare.

#### Radiographic Features {#s1125}

Plain film/HRCT ([Fig. 1-45](#f0230){ref-type="fig"} )•Numerous cystic spaces, 90%Size of cysts usually \<5 to 10 mmThin walledSurrounded by normal lung•Recurrent pneumothorax, 70%•Chylous pleural effusions, 25%•Plain film: overinflation, irregular opacities, cysts•Occasionally multiple nodules: multifocal micronodular pneumocyte hyperplasia Figure 1-45Lymphangiography•Obstruction of lymphatic flow at multiple levels•Dilated lymphatics•Increased number of lymphatics•Renal angiomyolipomas, which are often small and asymptomatic•Chylous ascites (in up to one third of patients), uterine leiomyomas, and lymphaticoureteral and lymphaticovenous communications•Abdominal and pelvic lymph angioleiomyomas•Abdominal lymph nodes

### Tuberous sclerosis {#s1130}

Identical lesions as in LAM

Collagen vascular diseases {#s1135}
--------------------------

Collagen vascular diseases have a common pathogenesis in the lung: immune response → inflammation (interstitial pattern, granuloma) → vasculitis → obstruction (e.g., respiratory insufficiency, PA hypertension).

###  {#s1140}

#### Pearls {#s1145}

•Lower lungs are more frequently affected (higher blood flow).•Vasculitides of large arteries (e.g., periarteritis nodosa) cause pulmonary hypertension.•Most common complication is infection (secondary to immunosuppressive medications).

### Rheumatoid arthritis (RA) {#s1150}

There are seven forms of pleuropulmonary disease associated with RA:Rheumatoid lung nodules, 20% (necrobiotic)•Usually multiple•Nodules may change in size rapidly or disappear completely.•Association between cutaneous and pulmonary nodulesPleural effusion and pleuritis•Clinically, pleuritis is the most common pulmonary feature of RA.•Effusions are bilateral in the majority of patients.•Proportionately more common in men•Fluid has low pH and low glucose.•Effusions are usually unilateral.Caplan syndrome•Nodular rheumatoid lung disease associated with pneumoconiosis fibrosing alveolitisConstrictive bronchiolitisLymphoid hyperplasiaPulmonary hypertension

#### Radiographic Features {#s1155}

•Bibasilar patchy alveolar opacities are early findings.•Dense reticulonodular pattern is most frequent•Pleural involvement, 20%•End stage: honeycombing, PAH

### Ankylosing spondylitis (AS) {#s1160}

•Pulmonary fibrocystic changes in 1%-10%•Upper lobe fibrotic scarring, infiltration, cystic airspaces•Ancillary findings:Ossification of spinal ligaments, sacroiliitisCardiomyopathy

### Systemic lupus erythematosus (SLE) {#s1165}

Pleural abnormalities are the most common findings.•Pleural thickening•Recurrent pleural effusions•Pleuritis is thought to be pathogenetically similar to polyserositis affecting joints.•Glucose level of pleural effusion is normal (decreased in RA). Pulmonary disease: wide spectrum of findings, but the usual presentation is as acute lupus pneumonitis:•Acute lupus pneumonitis: vasculitis and hemorrhage resulting in focal opacities at the lung bases•Alveolar opacities, which may progress to ARDS•Fibrosing alveolitis, rare•Elevating diaphragm, atelectasis at bases (shown to be due to diaphragmatic dysfunction)•Lupus-like disease can also be seen with drugs such as hydralazine and procainamide.

### Other collagen vascular diseases with pulmonary manifestations {#s1170}

•Progressive systemic sclerosis (PSS) exists in two forms:PSS with sclerodermaAfter esophagus, lung is the second most common site.Interstitial fibrosis is the most common pulmonary manifestation.Pulmonary vascular and pleural changes are less common.PSS with CREST (calcinosis, Raynaud, esophageal dysmotility, sclerodactyly, telangiectasia)Usually in older womenLong history of PSS with swollen fingersMild disease, slowly progressive, greater life expectancy•Polymyositis, dermatomyositis•Mixed connective tissue disease (MCTD)

Vasculitis and granulomatoses {#s1175}
-----------------------------

### Clinicoradiologic features suggestive of vasculitis {#s1180}

•Deforming of ulcerating upper airway lesions•Palpable purpura•Peripheral neuropathy•Rapidly progressive glomerulonephritis•Pulmonary renal syndrome•Chest imaging showing nodular or cavitary disease•Diffuse alveolar hemorrhage

### Wegener granulomatosis {#s1185}

Systemic granulomatous process with destructive angiitis involving lung, upper respiratory tract, and kidney (necrotizing glomerulonephritis); type IV immune mechanism. The upper respiratory tract is affected in almost all patients, with lungs and kidneys involved in 90% and 80% of patients, respectively.

#### Radiographic Features ([Fig. 1-46](#f0235){ref-type="fig"}) {#s1190}

•Multiple nodules with cavitation (common)•Interstitial, reticulonodular opacities at lung bases (earliest finding)•Diffuse opacities (common) are due to:Atelectasis: bronchoconstrictionConfluent nodules and massesPulmonary hemorrhageSuperimposed infection•Other findings:Pleural effusions, 25%Adenopathy (rare) Figure 1-46

### Lymphomatoid granulomatosis {#s1195}

Now considered a B-cell lymphoma. Men \> women. The multiple nodules are smaller than those in Wegener. Nodules are not numerous and tend to cavitate.

### Churg-strauss---allergic angiitis and granulomatosis {#s1200}

Similar to polyarteritis nodosa, but patients have pulmonary diseases and asthma. Affects skin, kidneys, lung, heart, and CNS; eosinophilia.

#### Radiographic Features {#s1205}

•Patchy peripheral areas of consolidation•Fleeting opacities•Multiple nodules

### Behçet disease {#s1210}

Chronic multisystem vasculitis, characterized by: •Recurrent oral and genital ulcerations•Uveitis•Additional clinical manifestations in multiple organ systems

#### Radiographic Features {#s1215}

•Pulmonary arterial aneurysm: fusiform to saccular, commonly multiple and bilateral, located in the lower lobe or main pulmonary arteries•Thickening of the aorta and SVC (vasculitis)•Subpleural alveolar infiltrates, and wedge-shaped or rounded areas of increased density, which represent focal vasculitis and thrombosis resulting in infarction, hemorrhage, and focal atelectasis

Other chronic disorders {#s1220}
-----------------------

### Langerhans cell histiocytosis (eosinophilic granuloma) {#s1225}

Langerhans cell histiocytosis consists of three clinical syndromes:Letterer-Siwe: acute disseminated formHand-Schüller-Christian: chronic disseminated formEosinophilic granuloma:•Solitary bone lesion•Small cystic spaces in lung parenchyma•3- to 10-mm pulmonary nodules•Apical reticulonodular pattern•Pneumothorax, 30%

### Idiopathic pulmonary hemorrhage (IPH) {#s1230}

Recurrent pulmonary hemorrhage, which may result in interstitial fibrosis. Age usually \<10 years.

#### Radiographic Features {#s1235}

•Diffuse airspace pattern (radiographic appearance similar to Goodpasture syndrome)•Hilar adenopathy

### Amyloid {#s1240}

Extracellular deposition of protein derived from light chains of monoclonal Ig.

#### Classification {#s1245}

•Primary amyloid: heart, lung (70%), skin, tongue, nerves•Amyloid associated with multiple myeloma (carpal tunnel syndrome, common)•Secondary amyloid (liver, spleen, kidney) in:Chronic infectionsChronic inflammationsNeoplasm•Heredofamilial amyloidosis (familial Mediterranean fever; other syndromes)•Local amyloidosis in isolated organs•Amyloid associated with aging

#### Radiographic Features {#s1250}

•Adenopathy and calcifications are common.•Plain film findings are nonspecific, with multiple nodules or diffuse linear patterns.•Pulmonary involvement can be either diffuse or focal.•Diagnosis requires biopsy.

### Neurofibromatosis {#s1255}

Twenty percent of patients with neurofibromatosis have pulmonary involvement:•Progressive pulmonary fibrosis•Bullae in upper lobes and chest wall•Chest wall and mediastinal neurofibromas•Intrathoracic meningoceles•Ribbon deformities of the ribs

### Pulmonary alveolar microlithiasis {#s1260}

Tiny calculi within alveoli. Unknown cause (hereditary). Rare.

#### Radiographic Features {#s1265}

•Sandlike microcalcifications of lung (black pleura sign)•Bilateral, symmetrical involvement•Pulmonary activity on bone scan

### Alveolar proteinosis {#s1270}

Proteinaceous, lipid-rich surfactant from type II pneumocytes accumulates in alveoli. Unknown etiology (may be associated with lymphoma or acute silicosis). Extensive sputum production (liters/day). Diagnosed with biopsy, sputum electron microscopy for alveolar phospholipids. Prognosis: Some people with pulmonary alveolar proteinosis suffer from shortness of breath for their entire lifetime. However, this lung disorder is rarely fatal as long as patients undergo regular lung washings. Complications include nocardiosis, aspergillosis, cryptococcosis, and lymphoma. Treatment is with aerosolized proteolytic agents and bronchoscopic lung lavage with 10 to 20 L saline (therapy of choice).

#### Radiographic Features {#s1275}

•Bilateral, symmetrical airspace disease (butterfly, batwing pattern)•Acinar pattern may become confluent (consolidation)•CT: multifocal, panlobular, ground-glass, and airspace opacities with septal thickening ("crazy paving")•Other findings from superimposed opportunistic infection

### Drug-induced lung disease {#s1280}

A large number of therapeutic drugs can cause lung toxicity. Because the findings are often nonspecific, a high index of suspicion is required. The most common abnormalities are:Diffuse interstitial opacities•Cytotoxic agents: bleomycin, methotrexate, carmustine, cyclophosphamide•Gold saltsPulmonary nodules (uncommon)•Cyclosporine•Oil aspirationFocal ASD•Amiodarone accumulates in lysosomes of phagocytes; high iodine content results in increased CT density of affected lung and liverDiffuse ASD (pulmonary edema, hemorrhage)•Cytotoxic agents: cytarabine, IL-2, OKT3•Tricyclic antidepressants•Salicylates•Penicillamine•AnticoagulantsAdenopathy•Phenytoin (Dilantin)•Cytotoxic agents: cyclosporine, methotrexatePleural effusions•Drug-induced SLE•Bromocriptine•Methysergide, ergotamine tartrate

Inhalational Lung Disease {#s1285}
=========================

Pneumoconiosis {#s1290}
--------------

Pneumoconioses are caused by inhalation of inorganic dust particles that overwhelm the normal clearance mechanism of the respiratory tract.

###  {#s1295}

#### Types {#s1300}

Benign pneumoconiosis: radiographic abnormalities are present while there are no symptoms or only minimal symptoms (not fibrogenic):•Tin = stannosis•Barium = baritosis•Iron = siderosisFibrogenic pneumoconiosis (symptomatic)•Silica = silicosis•Asbestos = asbestosis•Coal workers\' pneumoconiosis (CWP)

### International labor organization (ILO) classification ([Fig. 1-47](#f0240){ref-type="fig"}) {#s1305}

The ILO classification can be used to classify or follow pneumoconioses. All pneumoconioses have similar radiographic features that range from few tiny nodules to end-stage lung disease.Small opacitiesSize:•Nodules: p = \<1.5 mm, q = \<3 mm, r = \>3 to 10 mm•Reticular: s = fine, t = medium, u = coarse•Reticulonodular: x = fine, y = medium, z = coarse (this is not part of ILO classification)Location ("zone"): upper middle and lower zone of each lung fieldHow many (profusion = concentration): category 1 = few nodules, category 2 = lung markings still visible, category 3 = lung markings obscuredLarge opacitiesSize: A = \<5 cm, B = half of upper lung zone affected, C = \> half of upper lung zone affectedOther featuresPleural thickening, plaquesPleural calcification, diffuse Figure 1-47

### Silicosis {#s1310}

Causative agent is silicone dioxide (SiO~2~) in quartz, cristobalite, and tridymite. The severity of disease is related to the total amount of inhaled dust. Inhaled particles need to be \<5 μm in diameter because larger particles are removed by upper airways. Treatment is to stop exposure; however, in contrast to CWP, silicosis may be progressive despite removal from a dust environment. Isoniazid (INH) chemoprophylaxis is advised. Occupations most at risk (only 5% of patients with \>20 years\' exposure will develop a complicated form of pneumoconiosis) are:•Mining (gold, tin, copper, mica)•Quarrying (quartz)•Sandblasting

#### Pathology {#s1315}

•Silica is phagocytosed by pulmonary macrophages.•Cytotoxic reaction causes formation of noncaseating granuloma.•Granulomas develop into silicotic nodules (2 to 3 mm in diameter).•Pulmonary fibrosis develops as nodules coalesce.

#### Clinical Findings ([Fig. 1-48](#f0245){ref-type="fig"}) {#s1320}

Chronic silicosis•20 to 40 years of exposure•Predominantly affects upper lobes•Rarely develops into massive fibrosisAccelerated silicosis•5 to 15 years of heavy exposure•Middle and lower lobes are also affected.•Radiographic appearance is similar to that of alveolar proteinosis.•Concomitant diseases:TB, 25% (silicotuberculosis)Collagen vascular disease, 10% (scleroderma, RA, SLE, Caplan syndrome)Acute silicosis (silicoproteinosis)•\<3 years of exposure•Fulminant course: diffuse multifocal ground-glass or airspace consolidations•TB, 25%Caplan syndrome•RA•Lung disease:Silicosis (less common) or CWP (more common)Rheumatoid nodules Figure 1-48

#### Radiographic Features {#s1325}

Nodular pattern (common)•Nodules: 1 to 10 mm•Calcific nodules, 20%•Upper lobe \> lower lobe•Coalescent nodules cause areas of conglomerate opacities.Reticular pattern (may precede or be associated with the nodular pattern)Hilar adenopathy•Common•Eggshell calcification, 5%Progressive massive fibrosis (PMF)•Masses (\>1 cm) formed by coalescent nodules•Usually in posterior segment of upper lobes•Vertical orientation•Cavitation due to ischemia or superinfection from TB•Often bilateral•Retracts hila superiorly•Main differential diagnosis: neoplasm, TB, fungusConcomitant TB

### Coal workers\' pneumoconiosis (CWP) {#s1330}

Development of pneumoconiosis depends on the kind of inhaled coal: anthracite (50% incidence of pneumoconiosis) \> bituminous \> lignite (10% incidence).

Pathology: coal macule around respiratory bronchioli with associated focal dust (centrilobular emphysema).

#### Radiographic Features {#s1335}

Radiographically indistinguishable from silicosis•Simple (reticulonodular) pneumoconiosisUpper and middle lobe predominanceNodules: 1 to 5 mmCentriacinar emphysema surrounds nodules.•Complicated pneumoconiosis with progressive massive fibrosisUsually evolves from simple CWPMass lesions \>1 cm in diameter

### Asbestos {#s1340}

Asbestos exposure causes a variety of manifestations:Pleura•Pleural plaques (hyalinized collagen)•Diffuse thickening•Benign pleural effusion (most common manifestation)•Pleural calcificationLung•Interstitial fibrosis (asbestosis)•Rounded atelectasis with comet tail sign of vessel leading to atelectatic lung•Fibrous massesMalignancy•Malignant mesothelioma•Bronchogenic carcinoma•Carcinoma of the larynx•GI malignanciesPathogenicity of fibers: crocidolite (South Africa) \> amosite \> chrysotile (Canada).High-risk professions:•Construction, demolition•Insulation•Pipefitting and shipbuilding•Asbestos mining

### Asbestos-related pleural disease {#s1345}

#### Focal Pleural Plaques {#s1350}

Hyalinized collagen in submesothelial layer of parietal pleura. Focal interrupted areas of pleural thickening.•Pleural plaques have no functional significance.•Most common manifestation of asbestos exposure•Preferred location: bilateral, posterolateral mid and lower chest•Only 15% of pleural plaques are visible by CXR.

#### Diffuse Pleural Thickening {#s1355}

•Less frequent than focal plaques•Unlike focal plaques, diffuse thickening may cause respiratory symptoms (abnormal pulmonary function test results)•Thickening of interlobar fissures•May be associated with round atelectasis

#### Pleural Calcifications {#s1360}

Pleural calcification in the absence of other histories (hemothorax, empyema, TB, previous surgery) is pathognomonic of asbestos exposure.•Calcium may form in center of plaques.•Contains uncoated asbestos fibers but no asbestos bodies•Usually requires \>20 years to develop

#### Benign Pleural Effusions {#s1365}

Early sign of asbestos-related disease. Usually sterile, serous exudate. The diagnosis is one of exclusion: rule out other causes of pleural effusion:•Malignant mesothelioma•Bronchogenic carcinoma•TB

#### Round Atelectasis {#s1370}

Round-appearing peripheral atelectasis associated with pleural thickening. Although not unique to asbestos exposure, round atelectasis is common in patients with asbestos exposure and pleural thickening. Most commonly in posterior part of lower lobe.

#### Radiographic Features ([Fig. 1-49](#f0250){ref-type="fig"}) {#s1375}

•Round mass in lung periphery•Thickened pleura (due to asbestos-related disease)•Mass is most dense at its periphery.•Mass is never completely surrounded by lung.•Atelectasis forms an acute angle with pleura.•Comet sign: bronchi and vessels curve toward the mass.•Signs of volume loss: displaced fissure Figure 1-49

### Asbestosis {#s1380}

Refers exclusively to asbestos-related interstitial pulmonary fibrosis.

#### Radiographic Features {#s1385}

•Reticular, linear patterns•Initial subpleural location•Progression from bases to apices•Honeycombing occurring later in the disease•No hilar adenopathy

### Malignancy in asbestos-related disease {#s1390}

•7000-fold increase of mesothelioma (10% risk during lifetime; latency \>30 years after exposure)•7-fold increase of bronchogenic carcinoma•3-fold increase of GI neoplasm

Antigen-antibody--mediated lung disease {#s1395}
---------------------------------------

Allergic reactions in lung can cause one of four patterns of disease:•Granulomatous alveolitisHypersensitivity alveolitisChronic beryllium disease•Pulmonary eosinophilia (pulmonary infiltrations with eosinophilia \[PIE\])•Asthma•Goodpasture syndrome

### Hypersensitivity pneumonitis (extrinsic allergic alveolitis) {#s1400}

Granulomatous inflammation of bronchioles and alveoli caused by immunologic response to inhaled organic material. Type III (Ag-Ab complex mediated) and type IV (cell mediated) hypersensitivity reactions. Antigens are often fungal spores or avian-related antigens.Hypersensitivity AlveolitisDiseaseAntigen SourceAntigenFarmer\'s lungMoldy hay*Micropolyspora faeni*Bird fancier\'s lung (pigeons, parakeets)Avian excretaAvian serum proteinsHumidifier lungContaminated air conditionersThermophilic *Actinomyces*BagassosisMoldy bagasse dust*Thermoactinomyces sacchari*Malt worker\'s lungMoldy malt*Aspergillus clavatus*Maple bark stripper\'s lungMoldy maple bark*Cryptostroma corticale*Mushroom worker\'s lungSpores from mushroomsThermophilic *Actinomyces*

#### Radiographic Features {#s1410}

Acute, reversible changes•Diffuse ground-glass pattern•Reticulonodular interstitial pattern•Patchy areas of consolidation (rare)Chronic, irreversible changes•Progressive interstitial fibrosis (often upper lobe predominance) with honeycombing•Pulmonary hypertension

### Chronic beryllium disease {#s1415}

T-cell--dependent granulomatous response to inhaled beryllium (beryllium copper alloy, fluorescent strip lighting). Now a rare disease.

#### Radiographic Features {#s1420}

Many similarities to sarcoidosis:•Reticulonodular pattern → fibrosis•Bilateral hilar lymph node enlargementDistinction between berylliosis and sarcoidosis:•History of exposure to beryllium•Positive beryllium transformation test•Increased concentration of beryllium in lung or lymph nodes•Negative Kveim test

### Pulmonary infiltrates with eosinophilia (PIE) {#s1425}

Group of diseases characterized by transient pulmonary opacities and eosinophilia (\>500/mm^3^).

#### Types {#s1430}

Löffler syndrome (Simple pulmonary eosinophilia, SPE)•Idiopathic origin•Benign transient pulmonary opacities•Minimally symptomatic, self-limited•RareAcute eosinophilic pneumonia•Acute febrile illness \<5 days•Hypoxemia•Diffuse alveolar or mixed alveolar-interstitial opacities•Response to steroids with no relapse after discontinuation of steroids•\>25% in BAL fluidChronic eosinophilic pneumonia (idiopathic origin)•Severe, chronic pneumonia•Predominantly nonsegmental peripheral opacitiesPneumonias of known origin:•Allergic bronchopulmonary mycoses (type 1 + 2 hypersensitivity)*Aspergillus* (ABPA is the most important one)Rare: *Candida, Curvularia lunata, Drechslera hawaiiensis, Helminthosporium, Stemphylium lanuginosum*•Helminth infection (nodular opacities, very high eosinophilia count, high IgE):*Ascaris*Schistosomiasis; 50% with pulmonary involvement*Toxocara canis*Microfiliariasis•DrugsPenicillin, tetracycline, sulfonamidesSalicylatesChlorpropamide, imipramineNitrofurantoin (causes chronic interstitial eosinophilic alveolitis with progression to fibrosis)

### Goodpasture syndrome {#s1435}

Three main features: pulmonary hemorrhage, iron-deficiency anemia, and glomerulonephritis. Binding of circulating antibodies to glomerular and alveolar basement membranes. Symptoms include hemoptysis and renal failure. Diagnosis is made by antiglomerular basement membrane antibody, immunofluorescence of antibody, and renal biopsy.

#### Radiographic Features {#s1440}

•Pulmonary hemorrhage: consolidation with air bronchogram•Clearing of pulmonary hemorrhage in 1 to 2 weeks•Repeated hemorrhage leads to hemosiderosis and pulmonary fibrosis → interstitial reticular pattern•Renal findings

Toxin-induced interstitial pneumonitis/fibrosis {#s1445}
-----------------------------------------------

### Drug-induced pulmonary toxicity {#s1450}

Chemotherapeutic drugs•Bleomycin•BCNU•Cyclophosphamide•Methotrexate•ProcarbazineOther drugs•Amiodarone•Nitrofurantoin•Gold•Carbamazepine

### Silo filler disease {#s1455}

•Due to NO~2~ production (yellow gas) in silos•NO~2~ forms nitric acid (HNO~3~) in lungs, causing pulmonary edema and later COP.•Silo filler disease only occurs in September and October, when silos are being filled.•Safe NO~2~ levels below 5 ppm

Airway Disease {#s1460}
==============

Trachea {#s1465}
-------

### Malignant tracheal neoplasm {#s1470}

Ninety percent of all tracheobronchial tumors are malignant.

#### Types {#s1475}

Primary malignancies•SCC (most common)•Adenoid cystic carcinoma (second most common)•Mucoepidermoid (less common)•Carcinoid (less common; strong contrast enhancement, octreotide uptake)Metastases•Local extension (common)Thyroid cancerEsophageal cancerLung cancer•Hematogenous metastases (rare)MelanomaBreast cancer

### Benign neoplasm {#s1480}

Only 10% of tracheobronchial tumors are benign. Benign tumors are typically \<2 cm.

#### Types {#s1485}

Papilloma•Common laryngeal tumors in children, rare in adults, often multiple•May cause lung nodules•Malignant potential-SCC. (These lesions are caused by the human papillomavirus and are benign but may degenerate into malignancies.)Hamartoma•Fat density is diagnostic.•Often calcified (popcorn pattern)Adenoma•Rare

### Saber-sheath trachea {#s1490}

Reduced coronal diameter (\<⅔ of sagittal diameter). Only affects the intrathoracic trachea; the extrathoracic trachea appears normal.•95% of patients have COPD•More common in male patients•Tracheal ring calcification is common.

### Tracheopathia osteoplastica (TPO) {#s1495}

Foci of cartilage and bone develop in the submucosa of the tracheobronchial tree. Benign, rare condition. Most cases are discovered incidentally at autopsy.

#### Clinical Findings {#s1500}

•Dyspnea, hoarseness, expiratory wheeze/stridor (airway obstruction)•Hemoptysis (mucosal ulceration)•Cough and sputum production•Rarely: atelectasis, pneumonia

#### Radiographic Features {#s1505}

•Calcified tracheobronchial tree, nodules, osteocartilaginous growth•Thickening of tracheal cartilage•Sparing of the posterior membranous portion•Narrowed lumen•Distal three fourths of the trachea and the proximal bronchi are most commonly involved.

### Relapsing polychondritis {#s1510}

Collagen vascular disease characterized by inflammation and progressive destruction of cartilage throughout the body (ribs, trachea, earlobes, nose, joints). Rare.

#### Diagnostic Criteria (\>3 needed) {#s1515}

•Recurrent chondritis of auricles (painful ear)•Inflammation of ocular structures (e.g., conjunctivitis, scleritis, keratitis)•Chondritis (painful) of laryngeal/tracheal cartilage•Cochlear or vestibular damage

#### Radiographic Features {#s1520}

Trachea•Diffuse narrowing (slitlike lumen)•Thickening of tracheal wallLocation•Ear, 90%•Joints, 80%•Nose, 70%•Eye, 65%•Respiratory tract, 55%•Inner ear, 45%•Other: cardiovascular, 25%; skin, 15%

### Tracheobronchomalacia {#s1525}

Refers to weakening of tracheal and bronchial walls.Primary (uncommon)•Occurs in children•May be associated with laryngomalaciaSecondary (more common)•Intubation•COPD•Less common causes: recurrent infections, trauma, relapsing polychondritis•Compression of trachea by vessels or mediastinal mass

#### Radiographic Features {#s1530}

•Collapsed walls of trachea and bronchi•Recurrent pneumonia

### Tracheobronchomegaly (mounier-kühn disease) {#s1535}

Atrophy and dysplasia of trachea and proximal bronchi. Associated with Ehlers-Danlos syndrome. The trachea measures \>3 cm, and/or bronchi measure \>2.4 cm. Tracheal diverticula.

### Congenital bronchial atresia {#s1540}

Narrowing or obliteration of a subsegmental, segmental, or lobar bronchus.•LUL \> RUL \> RML \> RLL, LLL•Mucus plugging of dilated distal bronchus•Collateral ventilation distal to obstruction with air trapping → distal lung is hyperlucent

Chronic bronchial disease {#s1545}
-------------------------

Group of diseases characterized by increased airway resistance and reduction in expiratory flow. Entities include chronic bronchitis, emphysema, asthma, bronchiectasis, and cystic fibrosis. The most common combination is chronic bronchitis and emphysema, often referred to as chronic obstructive pulmonary disease.

### Chronic obstructive pulmonary disease (COPD) {#s1550}

COPD is characterized by progressive obstruction to airflow. Two components:•Chronic bronchitis is a clinical diagnosis: excessive mucus formation and cough for \>3 months during 2 consecutive years; all other causes of expectoration have to be ruled out. The diagnosis of chronic bronchitis is based on clinical history; chest films add little information except to exclude other underlying abnormalities.•Emphysema is a pathologic diagnosis: abnormal enlargement of airspace distal to the terminal nonrespiratory bronchiole.The exact etiology of COPD is unknown:•Tobacco smoke•Industrial air pollution•α~1~-Antitrypsin deficiency (autodigestion)

#### Clinical Syndromes {#s1555}

Blue bloaters•Bronchitis, tussive type of COPD•Episodic dyspnea due to exacerbation of bronchitis•Young patientsPink puffers•Emphysematous type of COPD•Progressive exertional dyspnea due to the emphysema•Elderly patients

#### Radiographic Features {#s1560}

Features are nonspecific:Tubular shadows (thickened bronchial walls)•Parallel shadows if bronchiole is imaged in longitudinal section•Thickening of bronchi imaged in axial section.•Increased lung markings ("dirty chest")•Accentuation of linear opacities throughout the lung•Very subjective finding

### Emphysema {#s1565}

Abnormal enlargement of distal airspaces with destruction of alveolar walls with or without fibrosis. Underlying cause: imbalance of proteases and antiproteases.

#### Clinical Findings {#s1570}

•Chronic airflow obstruction•Decreased FEV~1~ Types of Emphysema[\*](#tf0030){ref-type="table-fn"}PanacinarCentroacinarParaseptalPredominant locationLower lobesUpper lobesAlong septal lines (periphery of lung and branch points of vessels)DistributionHomogeneousPatchyPeripheralAssociationsα~1~-Antitrypsin deficiency, smokingChronic bronchitis, smokingSmokingInvolvementAll components of acinus homogeneously involvedCenter of pulmonary acinus involvedUsually entire secondary pulmonary lobuleImaging![](u01-06-9780323065382.gif)![](u01-07-9780323065382.gif)![](u01-08-9780323065382.gif)[^4]

#### Radiographic Features ([Fig. 1-50](#f0255){ref-type="fig"}) {#s1575}

Overinflation•Flattening of hemidiaphragms (reliable sign): highest level of the dome is \<1.5 cm above a straight line drawn between the costophrenic and the vertebrophrenic junctions.•Tenting of diaphragm (invagination of thickened visceral pleura attached to septa between basal bullae)•Saber-sheath trachea•Other, less reliable signs:Increase of retrosternal airspace \>3 cm measured at level 3 cm below the sternomanubrial junctionCraniocaudal diameter of lung \>27 cmAnterior bowing of sternumAccentuated kyphosisWidely spaced ribsVascular abnormalities•Decreased number of vessels in areas of abnormal lung•Absence of peripheral pulmonary vessels•Fewer arterial branches•Central pulmonary artery increased in sizeEmphysema•Decreased attenuation of abnormal lung•An air-fluid level indicates infection of a bulla.HRCT•Centriacinar (centrilobular): the central portion of the pulmonary lobule is involved.•Panacinar (panlobular): the whole acinus is involved, and central arteries and bronchioles can be seen (usually at apices).•Paraseptal: emphysematous changes adjacent to septal lines in periphery and along fissuresPearls•As emphysema becomes more severe with time, the CT differentiation of the three types of emphysema becomes more difficult.•Different types of emphysema may coexist.•Moderate to severe emphysema can be detected on CXR; for the detection of mild forms HRCT is usually required.•HRCT is currently the most sensitive method to detect emphysema; however, normal HRCT does not rule out the diagnosis of emphysema.•Always look at CXR before interpreting HRCT; occasionally, CXR changes of emphysema are more evident than HRCT changes (e.g., hyperinflation).•20% of patients with emphysema have normal HRCT.•40% of patients with abnormal HRCT have normal pulmonary function tests.•Bullous lung disease is a severe form of emphysema that is highly localized and \>1 cm in size. Figure 1-50

### Asthma {#s1580}

Hyperirritability of airways causes reversible airway obstruction (bronchial smooth muscle contraction, mucosal edema, hypersecretion of bronchial secretory cells: bronchospasm). The etiology is unknown (IgE participation).

#### Types {#s1585}

Extrinsic, allergic form•Childhood asthma•Immunologically mediated hypersensitivity to inhaled antigensIntrinsic asthma•Adults•No immediate hypersensitivity

#### Radiographic Features {#s1590}

Normal CXR in majority of patientsSevere or chronic asthma:•Air trapping, hyperinflation: flattened diaphragm, increased retrosternal airspace•Limited diaphragmatic excursionBronchial wall thickening (tramlines), a nonspecific finding, is also seen in chronic bronchitis, cystic fibrosis, bronchiectasis, and pulmonary edema.

#### Complications {#s1595}

•Acute pulmonary infection•Mucus plugs•Allergic bronchopulmonary aspergillosis (ABPA)•Tracheal or bronchial obstruction•Pneumomediastinum/pneumothorax

### Bronchiectasis {#s1600}

Irreversible dilatation of bronchi (reversible bronchial dilatation may be seen in viral and bacterial pneumonia). Recurrent pneumonias and/or hemoptysis Morphologic Classification of BronchiectasisCylindricalVaricoseCysticTerminal divisions[\*](#tf0015){ref-type="table-fn"}20184PathologyNot end stageDestroyed lungDestroyed lungCXR, HRCTFusiform dilatation, tramlines, signet signs ![](u01-09-9780323065382.gif)Tortuous dilatation rare ![](u01-10-9780323065382.gif)Saccular dilatation, "string of cysts," AFL common ![](u01-11-9780323065382.gif)[^5]occur. HRCT is now the method of choice for workup of bronchiectasis.

#### Types {#s1605}

Congenital (rare)•Abnormal secretions: cystic fibrosis•Bronchial cartilage deficiency: Williams-Campbell syndrome•Abnormal mucociliary transport: Kartagener syndrome•Pulmonary sequestrationPostinfectious (common)•Childhood infection•Chronic granulomatous infection•ABPA•MeaslesBronchial obstruction•Neoplasm•Inflammatory nodes•Foreign body•Aspiration

#### Radiographic Features {#s1610}

Plain film•Tramline: horizontal, parallel lines corresponding to thickened, dilated bronchi•Bronchial wall thickening (best seen end-on)•Indistinctness of central vessels due to peribronchovascular inflammation•AtelectasisHRCT ([Fig. 1-51](#f0260){ref-type="fig"} )•Conspicuous bronchiBronchi can be seen in outer third of lung.Bronchi appear larger than accompanying vessels. Figure 1-51•Bronchial wallsThickened wallsSignet ring sign: focally thickened bronchial wall adjacent to pulmonary artery branch

#### Pearls {#s1615}

•Bronchography may be indicated if clinical suspicion of bronchiectasis is high and CT is negative; CT has a low positive predictive value for mild forms of bronchiectasis. Bronchography is rarely performed alone.•Differentiation of cystic bronchiectasis and cystic spaces in IPF (honeycombing) is difficult; bronchiectasis usually involves lower lobes; honeycombing is not associated with air-fluid levels.•To distinguish emphysema from bronchiectasis, expiratory scans will show air trapping in bullae; cystic bronchiectasis will collapse.

### Cystic fibrosis {#s1620}

Caused by an abnormality in the cystic fibrosis transmembrane conductance regulator protein, which regulates the passage of ions through membranes of mucus-producing cells. Autosomal recessive disease (incidence 1:2000).

#### Pathophysiology {#s1625}

•Dysfunction of exocrine glands causing thick, tenacious mucus that accumulates and causes bronchitis and pneumonia•Reduced mucociliary transport: airway obstruction with massive mucus pluggingSpectrum of diseasePulmonary, 100%•Chronic cough•Recurrent pulmonary infections: colonization of plugged airways by *Staphylococcus* and *Pseudomonas*•Progressive respiratory failure•Finger clubbing: hypertrophic osteoarthropathy from hypoxemiaGI tract•Pancreatic insufficiency, 85%: steatorrhea, malabsorption•Liver cirrhosis•Rectal prolapse•Neonates: meconium ileus, meconium peritonitis, intussusceptionOther•Sinusitis: hypoplastic frontal sinus, opacification of other sinuses•Infertility in males

#### Radiographic Features {#s1630}

Severity of bronchiectasis•Mild: lumen equal to adjacent blood vessels•Moderate: lumen 2 to 3 times the size of adjacent blood vessels•Severe: lumen \>3 times the size of adjacent blood vesselsPeribronchial thickening•Wall thickness ≥ the diameter of adjacent blood vesselsMucus plugging•Determine number of pulmonary segments involved•Air trapping → increased lung volumes•Collapse, consolidation•BullaeLocation: predominantly upper lobes and superior segments of lower lobesOther•Reticular, cystic pattern of lung fibrosis•Prominent hila:AdenopathyLarge pulmonary arteries (PAH)•Recurrent pneumonias

#### Complications {#s1635}

Early•Lobar atelectasis (especially RUL)•PneumoniaLate•Respiratory insufficiency, hypertrophic osteoarthropathy•Recurrent pneumothorax (rupture of bullae or blebs)•Cor pulmonale and pulmonary arterial hypertension•Hemoptysis•*Aspergillus* superinfection

### Bronchiolitis obliterans {#s1640}

Bronchiolitis obliterans (Swyer-James syndrome, unilateral emphysema) refers to unilateral air trapping caused by obstruction of distal bronchioles.

#### Etiology of Adult Bronchiolitis {#s1645}

Obliterative•Exposure to toxic fumes•Bone marrow transplant•Viral infections•DrugsProliferative•Acute infectious•Respiratory bronchiolitis•COP•COPDAsthmaChronic bronchitis

#### CT Features {#s1650}

•Nodules with branching opacities: tree-in-bud appearance•Ground-glass attenuation and consolidation•Mosaic patternSeen with obliterative bronchiolitisMosaic pattern due to hypoxic vasoconstriction in areas of bronchiolar obstruction with redistribution to normal areasDecreased size and number of vessels in affected lung with air trapping on inspiration/expiration CT; thus the apparent ground-glass-appearing lung is normal.•Other nonspecific findingsBronchiectasisBronchial wall thickening

Lung Injury {#s1655}
===========

 {#s9800}

### Trauma {#s1660}

Four major mechanisms of injury:1.Direct impact2.Sudden deceleration (motor vehicle accident): sudden torsion at interfaces of fixed (e.g., paraspinal) and mobile (e.g., lung) components3.Spallation: broad kinetic shock wave, which is partially reflected at a liquid-gas interface, leading to local disruption of alveoli and supporting structures4.Implosion: low-pressure afterwave that causes rebound overexpansion of gas bubblesOther mechanisms of chest trauma include:•Posttraumatic aspiration•Inhalation injury•Increased capillary permeability: fat emboli, oligemic shock, neurogenic pulmonary edema

#### Pearls {#s1665}

•Radiographic and clinical evidence of lung trauma is often absent in the first 2 to 3 hours after trauma.•There is no consistent relationship between external chest wall injury and underlying lung injury, especially in children.•Radiographic studies usually underestimate the true extent of pulmonary trauma.

### Pneumothorax ([Fig. 1-52](#f0265){ref-type="fig"}) {#s1670}

Common causes:Iatrogenic•Percutaneous biopsy, 20%•Barotrauma, ventilator, 20%Trauma•Lung laceration•Tracheobronchial ruptureCystic lung disease•Bulla, bleb: often in healthy young men; 30% recurrence•Emphysema, asthma•PCP•Honeycombing: end-stage interstitial lung disease•Lymphangioleiomyomatosis (pneumothorax in 75% of cases)•Eosinophilic granuloma (pneumothorax in 20% of cases)Parenchymal necrosis•Lung abscess, necrotic pneumonia, septic emboli, fungal disease, TB•Cavitating neoplasm, osteogenic sarcoma•Radiation necrosisOther•Catamenial: recurrent spontaneous pneumothorax during menstruation, associated with endometriosis of pleura Figure 1-52

### Radiographic features ([Figs. 1-53](#f0270){ref-type="fig"} and [1-54](#f0275){ref-type="fig"}) {#s1675}

Appearance•Upright positionAir in pleural space is radiolucent.White line of the visceral pleura is distinctly visible.Volume loss of underlying lungSupine positionDeep sulcus sign: anterior costophrenic angle sharply delineatedDetection•Lateral decubitus (suspected side should be up, whereas it should be down for fluid); 5 mL of air detectable•Upright expiration film•CT most sensitiveSize of pneumothorax can be estimated but is rarely of practical use•Average distance (AD in cm) = (A + B + C)/3•% Pneumothorax ≈ AD (in cm) x 10, e.g.:AD of 1 cm corresponds to a 10% pneumothoraxAD of 4 cm corresponds to a 40% pneumothorax Figure 1-53Figure 1-54

### Tension pneumothorax ([Fig. 1-55](#f0280){ref-type="fig"}) {#s1680}

Valve effect during inspiration/expiration leads to progressive air accumulation in thoracic cavity. The increased pressure causes shift of mediastinum and ultimately vascular compromise. Treatment is with emergency chest tube placement.Figure 1-55

#### Radiographic Features {#s1685}

•Overexpanded lung•Depressed diaphragm•Shift of mediastinum and heart to contralateral side

### Percutaneous chest tube placement for pneumothorax {#s1690}

#### Indication {#s1695}

•All symptomatic pneumothoraces

#### Technique for Heimlich Valve Placement (for Biopsy-Induced Pneumothorax) {#s1700}

1.Entry: midclavicular line, 2nd to 4th anterior intercostal space2.Aspirate air with 50-mL syringe.3.Use small drainage kit that includes a Heimlich valve (one-way airflow system). During expiration, positive intrapleural pressure causes air to escape through the valve.

#### Technique for Chest Tube Placement (Any Pneumothorax) {#s1705}

1.Entry: posterior or lateral or region of largest pneumothorax as defined by CT2.Local anesthesia3.Place 12- to 16-Fr drainage catheter using trocar technique.4.Put catheter to wall suction.5.Catheter can be removed if there is no pneumothorax 24 hours after clamping of the catheter.

### Contusion {#s1710}

Endothelial damage causes extravasation of blood into interstitium and alveoli.

Occurs mainly in lung adjacent to solid structures (e.g., ribs, vertebrae, heart, liver).

Appears 6 to 24 hours after injury. Hemoptysis is present in 50%. Mortality rate of 15%-40%.

#### Radiographic Features {#s1715}

•Pulmonary opacities are due to hemorrhage and edema.•Air bronchograms are commonly seen by CT but are not always present if there is associated bronchial obstruction.•Contusions usually appear 6 to 24 hours after trauma and resolve by 7 to 10 days.•Opacities that do not resolve by 7 to 10 days may represent:Postlaceration hematomaAspirationHospital-acquired pneumoniaAtelectasisARDS

### Lung laceration ([Fig. 1-56](#f0285){ref-type="fig"}) {#s1720}

Produced by sharp trauma (rib fractures), deceleration, shearing, or implosion. Pathogenetically, there is a linear tear (may be radiographically visible) that becomes round or ovoid (pneumatocele) with time. Usually accompanied by hemoptysis and pleural and parenchymal hemorrhage. Bronchopleural fistulas are a common complication. Detection of a laceration is clinically important as lacerations can become secondarily infected and also lead to bronchopleural fistula, requiring prolonged chest tube drainage.Figure 1-56

Types of Pulmonary LacerationsTypeLocationPneumothoraxMechanism1MidlungVariableShear between parenchyma and tracheobronchial tree2ParaspinalUncommonShear due to sudden herniation of lower lobe parenchyma in front of vertebral column3SubpleuralUsualPuncture by displaced rib fracture4SubpleuralUsualShear at site of transpleural adhesion

### Fat embolism {#s1725}

Lipid emboli from bone marrow enter pulmonary and systemic circulation. When complicated by ARDS, fat embolism has high mortality. Frequently CNS is also affected.

#### Radiographic Features {#s1730}

•Subject in patients with initially clear lungs, sudden onset of dyspnea, and multiple fractures.•Interstitial and alveolar hemorrhagic edema produces a varied radiographic appearance.•Radiographic opacities induced by fat embolism become evident only 48 hours after the incident ("delayed onset").•Opacities clear in 3 to 7 days.

### Tracheobronchial tear {#s1735}

High mortality (30%). Requires early bronchoscopy for early detection to avoid later bronchostenosis. Two presentations:•Tear of right mainstem and distal left bronchus: pneumothorax not relieved by chest tube placement. Most common locations are main bronchi (R \> L); 75% occur within 2 cm of tracheal carina.•Tear of trachea and left mainstem bronchus: air leaks are usually confined to mediastinum and subcutaneous tissues.

### Diaphragmatic tear {#s1740}

Ninety percent of tears occur on the left side, 90% of clinically significant hemidiaphragm ruptures are overlooked initially, and 90% of strangulated diaphragmatic hernias are of traumatic etiology.

#### Radiographic Features ([Fig. 1-57](#f0290){ref-type="fig"}) {#s1745}

•Air-fluid levels or abnormal air collection above diaphragm•Abnormal elevation of left hemidiaphragm with or without herniated gastric fundus or colon•Contralateral tension displacement of mediastinum•Abnormal location of NG tube•Confirmation of tear by coronal MRI Figure 1-57

### Esophageal tear {#s1750}

•Esophageal tear (thoracic inlet, gastroesophageal junction)•Blunt injuries usually seen in phrenic ampulla and cervical esophagus, whereas penetrating injuries can occur anywhere.•Chest radiographs are nonspecific and usually show wide mediastinum, left pleural effusion, or hydropneumothorax.•Pneumomediastinum is common but is a nonspecific finding.•Pleural effusion has low pH and high amylase levels.

### Other injuries {#s1755}

•Aortic injury•Hemothorax•Chylothorax•Cardiac injury•Fractures: rib, spine

Postoperative chest {#s1760}
-------------------

### Complications of surgical procedures {#s1765}

#### Mediastinoscopy {#s1770}

Complication rate, \<2%:•Mediastinal bleeding•Pneumothorax•Vocal cord paralysis (recurrent nerve injury)

#### Bronchoscopy {#s1775}

•Injury to teeth, aspiration•Transient pulmonary opacities, 5%•Fever, 15%•Transbronchial biopsy:Pneumothorax, 15%Hemorrhage (\>50 mL), 1%

#### Wedge Resection {#s1780}

•Air leaks (common)•Contusion•Recurrence of tumor

#### Median Sternotomy Complications {#s1785}

Complication rate, 1%-5%:•Mediastinal hemorrhage•Mediastinitis (focal fluid collection)•Sternal dehiscence•False aneurysm•Phrenic nerve paralysis•Osteomyelitis of sternum

#### Chest Tube Placement {#s1790}

•Horner syndrome (pressure on sympathetic ganglion)•False aortic aneurysm

### Pneumonectomy ([Fig. 1-58](#f0295){ref-type="fig"}) {#s1795}

#### Radiographic Features {#s1800}

•Two thirds of the hemithorax fills with fluid in 4 to 7 days; it is important that successive films demonstrate gradual fill-in and that the residual air bubble does not get bigger; an air bubble increasing in size is suggestive of a bronchopleural fistula.•Gradual shift of the mediastinum and heart toward the pneumonectomy side•Contralateral lung may normally be herniated toward the pneumonectomy side at the apex and mimic the presence of a residual lung. Figure 1-58

#### Lobectomy {#s1805}

•Remaining lobes expand to fill the void; splaying of vessels•Slight shift of mediastinum, elevation of hemidiaphragm

#### (Sub)segmental Resection {#s1810}

•Little or no parenchymal rearrangement•Postoperative opacities (hemorrhage, contusion, edema) common

### Postpneumonectomy syndrome {#s1815}

This rare syndrome refers to airway obstruction that occurs after pulmonary resections and is due to an extreme shift of the mediastinum or rotation of hilar structures. Occurs most often after right pneumonectomy or after left pneumonectomy when a right arch is present.

#### Radiographic Features ([Fig. 1-59](#f0300){ref-type="fig"}) {#s1820}

Airway obstruction•Air trapping: hyperinflated lung•Recurrent pneumonia, bronchiectasisNarrowing of bronchi or trachea, bronchomalaciaPostsurgical changes•Hyperinflation of contralateral lung•Marked shift of mediastinum Figure 1-59

### Bronchopleural fistula (BPF) {#s1825}

A fistula between bronchus and pleural space develops in 2%-4% of pneumonectomy patients; with large fistulas, the fluid in the pneumonectomy cavity may drown the opposite healthy lung. Factors that predispose to BPF include:•Active inflammation (TB), necrotizing infection•Tumor in bronchial margin•Devascularized bronchial stump, poor vascular supply•Preoperative irradiation•Contamination of the pleural space

#### Radiographic Features {#s1830}

Plain film•Persistent or progressive pneumothorax•Sudden shift of mediastinum to the normal sideNuclear medicine•Xenon leakSinography with nonionic contrast material•Examination of choice to define the size of a pleural cavity and bronchial communication•Alternatively, thin section CT may show communication.

### Torsion {#s1835}

#### Lobar Torsion {#s1840}

A prerequisite for torsion is the presence of complete fissures. Predisposing factors include masses, pleural effusion, pneumothorax, pneumonia, and surgical resection of inferior pulmonary ligament. Rare.•Most commonly the right middle lobe (RML) rotates on its bronchovascular pedicle.•Obstruction of venous flow, ischemia, and necrosis result.•Plain film: mobile opacity at different locations on different views

#### Cardiac Herniation {#s1845}

Rare. 50%-100% mortality. Most often occurs after a right pneumonectomy requiring intrapericardial dissection.

#### Radiographic Features ([Fig. 1-60](#f0305){ref-type="fig"}) {#s1850}

•Heart is rotated to the right•Cardiac herniation through pericardial sac results in intrapericardial air, which originates from the postpneumonectomy space•Presence of a notch•Intracardiac catheters are kinked•"Snow cone" appearance of heart border Figure 1-60

### Lung transplantation {#s1855}

Transplantation of the left lung is technically easier because of the longer left bronchus.

#### Radiographic Features {#s1860}

Reimplantation response•Diffuse alveolar pattern of noncardiogenic pulmonary edema develops within 4 to 5 days in the transplanted lung owing to capillary leak. It never develops later.•The alveolar pattern lasts 1 to several weeks.Rejection•Acute rejection is most commonly detected by biopsy when there are no associated radiographic findings; when radiographic findings are present, they include:Diffuse interstitial pattern in peribronchovascular distributionSeptal thickeningPleural effusionAlveolar edema•Chronic rejectionBronchiolitis obliterans (air trapping on expiratory scans)BronchiectasisInfections, 50% of patients•Infections usually involve the transplanted lung, not the native lung, because of poor mucociliary clearance and/or lymphatic interruption.•Pathogens: *Pseudomonas, Staphylococcus \>* other bacterial, viral, fungal infectionsAirways•Leaks at bronchial anastomosis site are the most common abnormality and usually present as pneumomediastinum and/or pneumothorax in the perioperative period.•Operations to prevent leaksOmental flap around anastomosisTelescope-type anastomosis•Bronchial strictures may require stentingLymphoproliferative disorder•Multiple or solitary pulmonary nodules or lymphadenopathy

Pulmonary Vasculature {#s1865}
=====================

Pulmonary artery hypertension {#s1870}
-----------------------------

### General {#s1875}

PAH is defined as P~sys~ \>30 mm Hg or P~mean~ \>25 mm Hg. Normal pulmonary arterial pressures in adult:•P~sys~: 20 mm Hg•P~dias~: 10 mm Hg•P~mean~: 14 mm Hg•Capillary wedge pressure: 5 mm Hg

#### Causes of PAH {#s1880}

Primary PAH (females 10 to 40 years; rare)Secondary PAH (more common)•Eisenmenger syndrome•Chronic PE•Emphysema, pulmonary fibrosis•Schistosomiasis (most common cause worldwide)

#### Classification {#s1885}

Precapillary hypertensionVascular•Increased flow: L-R shunts•Chronic PE•Vasculitis•Drugs•IdiopathicPulmonary•Emphysema•Interstitial fibrosis•Fibrothorax, chest wall deformities•Alveolar hypoventilationPostcapillary hypertensionCardiac•LV failure•Mitral stenosis•Atrial tumorPulmonary venous•Idiopathic venoocclusive disease•Thrombosis

#### Radiographic Features {#s1890}

•Enlarged main PA (diameter correlates with pressure): \>29 mm is indicative of PAH.•Rapid tapering of PA toward the periphery•Decreased velocity of pulmonary flow by MRA•Calcification of the pulmonary arteries is pathognomonic but occurs late in the disease.•Cardiomegaly (cor pulmonale)•If the ratio of pulmonary artery diameter to aortic diameter is greater than 1 (rPA \>1) by CT, there is a strong correlation with elevated mean PA pressure, particularly in patients \<50 years of age. Types of Pulmonary EDEMASignsCardiacRenalLung InjuryHeart sizeEnlargedNormalNormalBlood flowInvertedBalancedNormalKerley linesCommonCommonAbsentEdemaBasilarCentral: butterflyDiffuseAir bronchogramsNot commonNot commonVery commonPleural effusionsVery commonCommonNot common![](u01-12-9780323065382.gif)•By HRCT scans, both primary and secondary forms of pulmonary hypertension may produce a mosaic pattern of lung attenuation, a finding suggestive of regional variations in parenchymal perfusion. A vascular cause for the mosaic pattern is suggested when areas of high attenuation contain larger-caliber vessels and areas of low attenuation contain vessels of diminished size.

Pulmonary edema {#s1895}
---------------

###  {#s2895}

#### Causes of Pulmonary Edema {#s1900}

CardiogenicAdults•Left ventricular (LV) failure from CAD (most common)•Mitral regurgitation (common)•Ruptured chordae•EndocarditisNeonates•TAPVC below diaphragm•Hypoplastic left side of heart•Cor triatriatumRenal•Renal failure•Volume overloadLung injury (increased permeability: capillary leak)•Septic shock, neurogenic shock•Fat embolism•Inhalation: SO~2~, O~2~, Cl~2~, NO~2~•Aspiration, drowning

### Grading of cardiogenic pulmonary edema ([Figure 1-61](#f0310){ref-type="fig"}, [Figure 1-62](#f0315){ref-type="fig"}, [Figure 1-63](#f0320){ref-type="fig"}) {#s1905}

Fluid accumulation in the lung due to cardiogenic causes (CHF; pulmonary venous hypertension) follows a defined pattern:Grade 1: vascular redistribution (10 to 17 mm Hg)•Diameter of upper lobe vessels equal to or increased over diameter of lower lobe vessels at comparable distance from hilum•Pulmonary veins in first intercostal space \>3 mm in diameterGrade 2: interstitial edema (18 to 25 mm Hg)•Peribronchovascular cuffing, perihilar haziness•Kerley lines (differential diagnosis: chronic fibrosis from edema, hemosiderin, tumor, etc.)•Unsharp central pulmonary vessels (perivascular edema)•Pleural effusionGrade 3: alveolar edema (\>25 mm Hg)•Airspace disease: patchy consolidation, air bronchograms Figure 1-61Figure 1-62Figure 1-63

### Asymmetrical pulmonary edema {#s1910}

•Gravitational (most common)•Underlying COPD (common)•Unilateral obstruction of pulmonary artery: PE•Unilateral obstruction of lobar pulmonary vein: tumor

Pulmonary embolism {#s1915}
------------------

Acute pulmonary embolism (PE) is associated with significant morbidity and mortality, causing 120,000 deaths/year in the United States.

###  {#s2900}

#### Types {#s1920}

•Incomplete infarct: hemorrhagic pulmonary edema without tissue necrosis; resolution within days•Complete infarct: tissue necrosis; healing by scar formation

#### Risk Factors {#s1925}

•Immobilization \>72 hours (55% of patients with proved PE have this risk factor)•Recent hip surgery, 40%•Cardiac disease, 30%•Malignancy, 20%•Estrogen use (prostate cancer, contraceptives), 6%•Prior deep vein thrombosis (DVT), 20%; risk factors:Myocardial infarctionThoracoabdominal surgeryPermanent pacemakerVenous catheters

#### Clinical Findings {#s1930}

•Chest pain, 90%•Tachypnea (\>16 breaths/min), 90%•Dyspnea, 85%•Rales, 60%•Cough, 55%•Tachycardia, 40%•Hemoptysis, 30%•Fever, 45%•Diaphoresis, 25%•Cardiac gallop, 30%•Syncope, 15%•Phlebitis, 35%

#### Radiographic Features {#s1935}

Radiographic signs are nonspecific and are present only if a significant infarction occurs

#### Imaging Algorithm {#s9000}

•CT pulmonary angiography with axial CT of the inferior vena cava and the iliac, femoral, and popliteal veins is the mainstay of PE evaluation. If the findings are equivocal and clinical suspicion remains high, additional imaging is required (V./Q. scan, pulmonary angiography).•V./Q. scan is preferred if iodinated contrast is contraindicated in the context of renal insufficiency or history of severe allergic reaction.•Patients who have symptoms of deep vein thrombosis but not of pulmonary embolism initially undergo US, which is a less expensive alternative. If the findings are negative, imaging is usually discontinued; if they are positive, the patient is evaluated for pulmonary embolism at the discretion of the referring physician.•In pregnant patients, CTA may be performed if there is high suspicion for PE and sonography fails to demonstrate lower extremity DVT. Axial CT of the IVC and the iliac, femoral, and popliteal veins is omitted.

#### Plain Film {#s1940}

•Westermark sign: localized pulmonary oligemia (rare)•Hampton hump: triangular peripheral cone of infarct = blood in secondary pulmonary lobules (rare); does not grow → should reduce in size on successive radiographs•Fleischner sign: increased diameter of pulmonary artery (\>16 mm) seen in acute PE. It usually disappears within a few days.•Cor pulmonale: sudden increase in size of RV, RA•Pulmonary edema, atelectasis, pleural effusion, 50%

#### CT Findings in PE {#s1945}

•Adequately performed CT studies are essentially \>90% sensitive and specific for large central emboli.•Intraluminal filling defect surrounded by contrast•Expanded unopacified vessel•Eccentric filling defect•Peripheral wedge-shaped consolidation•Pleural effusion•Allows evaluation of the inferior vena cava and the lower extremity veins to the knee•Anatomic pitfalls in CT diagnosis of acute PE: lymph nodes, impacted bronchi, pulmonary veins, pulmonary arterial catheters, and pulmonary artery sarcomas.•Technical pitfalls: respiratory or cardiac motion, poor bolus timing, quantum mottle, and edge-enhancing reconstruction algorithms

#### Scintigraphy {#s1950}

•Ventilation-perfusion mismatch

#### Angiography {#s1955}

•Constant intraluminal filling defects in PA•Complete cut-off of PA or its branches•Prolongation of the arterial phase; delayed filling and emptying of venous phase

Vasculitis {#s1960}
----------

Overview of Pulmonary VasculitidesSyndromePathologyOther Affected VesselsPolyarteritis nodosaNecrotizing vasculitisRenal, hepatic, and visceral aneurysmAllergic granulomatous angiitis (Churg-Strauss syndrome)Granulomatous vasculitisAllergic history, eosinophiliaHypersensitivity vasculitisLeukocytoclastic vasculitisSkin (common)Henoch-Schönlein purpura vasculitisLeukocytoclasticSkin, GI, renal involvement usualTakayasu arteritisGiant cell arteritisAortic archTemporal arteritisGiant cell arteritisCarotid branchesWegener granulomatosisNecrotizing granulomatous vasculitisUpper and lower respiratory tracts, glomerulonephritis

Venous abnormalities {#s1965}
--------------------

### Pulmonary arteriovenous malformation (AVM) {#s1970}

Abnormal communication between pulmonary artery and veins. A communication between systemic arteries and pulmonary veins is much less common (\<5%).

#### Types {#s1975}

Congenital, 60%•Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia)Acquired, 40%•Iatrogenic•Infection•Tumor

#### Radiographic Features {#s1980}

•Location: lower lobes, 70% \> middle lobe \> upper lobes•Feeding artery, draining veins•Sharply defined mass•Strong enhancement•Change in size with Valsalva/Mueller procedure

#### Complications {#s1985}

•Stroke, 20%•Abscess, 10% (AVM acts as a systemic shunt)•Rupture: hemothorax, hemoptysis, 10%

### Pulmonary varices {#s1990}

Uncommon lesions that are typically asymptomatic and do not require treatment. Usually discovered incidentally.

#### Radiographic Features {#s1995}

•Dilated vein•Usually near left atrium

#### Aortic Nipple {#s2000}

Normal variant (10% of population) caused by the left superior intercostal vein seen adjacent to the aortic arch. Maximum diameter of vein: 4 mm

### Pulmonary venoocclusive disease (PVOD) {#s2005}

In the typical form there is occlusion of small pulmonary veins. The proposed initial insult in PVOD is venous thrombosis, possibly initiated by infection, toxic exposure, or immune complex deposition.

#### Radiographic Features {#s2010}

•Edema without cephalization•Pleural effusions•Cardiomegaly•CT findingsSecondary pulmonary arterial hypertensionMarkedly small central pulmonary veinsCentral and gravity-dependent ground-glass lung attenuationSmoothly thickened interlobular septaNormal-sized left atriumCentrilobular nodules

Pleura {#s2015}
======

General {#s2020}
-------

### Normal pleural anatomy {#s2025}

•Visceral pleura: covers lung•Parietal pleura: covers rib (costal pleura), diaphragm (diaphragmatic pleura), mediastinum (mediastinal pleura)Visceral and parietal pleura are continued at the pulmonary hilum and continue inferiorly as the inferior pulmonary ligament. Normal pleura (0.2 to 0.4 mm) is not visible by CT. Pleural thickening is present when a stripe of soft tissue is seen internal to a rib.

### Diagnostic thoracentesis {#s2030}

Success rate 97%. Pneumothorax 1%-3% (\<with blind thoracentesis).

#### Indication {#s2035}

•Suspected malignancy•Suspected infection

#### Technique {#s2040}

1.Use US to determine skin entry site.2.Anesthetize skin and subcutaneous and deep tissues.3.Advance 18- to 22-gauge spinal needle into collection, going over the superior border of the rib to avoid the neurovascular bundle.4.Aspirate 20 to 100 mL.

### Therapeutic thoracentesis {#s2045}

Success rate, 95%. Pneumothorax 7%.

#### Indication {#s2050}

•Respiratory compromise from large pleural effusions

#### Technique {#s2055}

1.Perform diagnostic thoracentesis2.Skin nick3.Place 7- to 10-Fr catheters for therapeutic thoracentesis. Remove catheter.4.Obtain CXR to check for pneumothorax.

#### Expansion Pulmonary Edema {#s2060}

Pulmonary edema may occur as a result of rapid evacuation of large amounts of pleural effusion. We routinely evacuate 2 to 3 L without complications. Do not aspirate both lungs in the same sitting because of the risk of expansion pulmonary edema and/or bilateral pneumothoraces.

#### Vacuthorax {#s2065}

If the lung parenchyma is abnormally stiff (fibrosis), it cannot reexpand and fill the pleural space, resulting in a "vacuthorax." The patient is unlikely to benefit from thoracentesis in this circumstance.

### Pneumothorax management {#s2070}

Success rate, \>90%.

#### Indication for Intervention {#s2075}

•Symptomatic pneumothorax•Pneumothorax, \>20%•Enlarging pneumothorax on subsequent CXR•Tension pneumothorax•Poor lung function of contralateral lung disease

#### Technique {#s2080}

1.Two approaches•2nd to 4th anterior intercostal space, midclavicular line•6th to 8th intercostal space, midaxillary line or posterior2.Local anesthesia, skin nick3.Place 8- to 12-Fr catheters using a trocar technique. For the anterior approach, small Heimlich valve sets may be used.4.After the lung is fully reexpanded for 24 hours, the catheter is placed on water seal for 6 hours and then removed if there is no pneumothorax.

#### Persistent Pneumothorax in Patient with Chest Catheter {#s2085}

•Persistent leak from airways (bronchial injury, lung laceration)•Loculated pneumothorax•Anterior pneumothorax•Obstructed catheter

### Empyema drainage {#s2090}

Success rate, 80%. Complications (hemorrhage, lung injury), 2%.

#### Indication {#s2095}

•Pus on diagnostic thoracentesis•Positive Gram stain•Positive culture

#### Technique {#s2100}

1.Choose entry site adjacent to largest collection using US or CT.2.Local anesthesia3.Diagnostic tap with 18-gauge needle. Send specimen for bacteriologic testing.4.Choice of drainage catheters•10- to 16-Fr pigtail catheter for liquid effusions (usually placed by trocar technique)•24-Fr catheter for thick collections (usually placed by Seldinger technique); dilators: 8, 10, 12, 14, 16, 20, etc.5.Put catheter to suction.6.Intrapleural tPA may be necessary for loculated effusions. tPA, 4-6 mg, is administered in up to 50 mL saline twice daily. Each administration consists of a clamping the tube and a dwell time of 30 minutes, after which the tube is placed back on suction.

#### Complications {#s2105}

•Technical catheter problems (clogging: change for larger catheter)•Nonclearance of collection: surgical removal

Fluid collections {#s2110}
-----------------

### Pleural effusions {#s2115}

Excess fluid in the pleural space. There are two generic types: transudates and exudates:•Transudate: ultrafiltrate of plasma; highly fluid, low in protein, devoid of inflammatory cells•Exudate: increased permeability of microcirculation; rich in protein, cells, and debris

Differentiation Between Transudate and ExudateTransudateExudateProtein\<3 g/dL\>3 g/dLProtein (plasma/fluid)\<0.5\>0.5LDH\<200 IU \<70% of serum level\>200 IU \>70% of serum levelCommon causesCHF, renal failure cirrhosisInfection (parapneumonic), tumor, embolism

#### Causes {#s2120}

Tumor•Bronchogenic carcinoma•Pleural metastases•Malignant mesothelioma•LymphomaInflammation•Pneumonia, TB, empyema•Collagen vascular disease•Abdominal diseasePancreatitisSubphrenic abscessBoerhaave syndromeMeigs syndrome (benign ovarian fibroma)Cardiovascular•Congestive heart failure•Pulmonary embolism•Renal failureCongenital•Hydrops (neonate)Metabolic•HypoproteinemiaTrauma

#### Radiographic Features ([Fig. 1-64](#f0325){ref-type="fig"}) {#s2125}

Lateral decubitus films•Most sensitive: may detect as little as 25 mLPA, lateral films: blunting of costophrenic angles•Posterior costophrenic angle (\>75 mL required)•Lateral costophrenic angles (\>175 mL required)Large effusions•All cardiophrenic angles obliterated•Mediastinal shift•Elevated diaphragmSplit pleura sign (CT, MRI): loculated fluid between visceral and parietal pleura with thickening of pleura. Thickened pleura may enhance with IV contrast. Figure 1-64

### Empyema {#s2130}

Empyema refers to either pus in the pleural space or an exudate that contains organism on a Gram stain (polymicrobial anaerobe, 35%; mixed aerobe/anaerobe, 40%; culture negative, 20%). There are three stages in the development of an empyema.

OverviewParameterStage 1Stage 2Stage 3PathologyExudativeFibrinopurulentFibrinousWBC countNormal\>15,000/cm^3^\>15,000/cm^3^pHNormal\<7\<7GlucoseNormal\<40 mg/dL\<40 mg/dLLDH\>200 IU/L\>200 IU/L\>200 IU/LProtein\>3 g/L\>3 g/L\>3 g/LTreatmentAntibioticsPercutaneous drainageSurgery

#### Causes {#s2135}

•Postinfection (parapneumonic), 60%•Postsurgical, 20%•Posttraumatic, 20%

#### Radiographic Features {#s2140}

•Pleural fluid collection•Thick pleura•Pleural enhancement•Gas in empyema collection may be due to:BPF (common)Gas-forming organism (rare)•Empyema necessitans: spontaneous extension of empyema into chest wall, forming a subcutaneous abscess that may eventually open to skin and form a fistula. Causes: TB (70%), Actinomyces, Nocardia

Differentiation Between Empyema and AbscessAbscessEmpyemaCauseNecrotizing pneumonia (anaerobes, fungus)Abscess extends to pleura; trauma, surgeryShapeRoundElliptical along chest wallAir-fluid levelA=BA ≠ BMarginsSharp or irregularSharpWallThickThinLungNormal positionDisplacedPleuraNot seenSplitVessel/\
bronchiWithinDisplacedTreatmentAntibiotics, postural drainage, percutaneous drainage in nonrespondersPercutaneous drainage![](u01-13-9780323065382.gif)![](u01-14-9780323065382.gif)

### Chylothorax {#s2145}

Chylothorax is caused by disruption of the thoracic duct. Daily chyle production of 1.5 to 2.5 L. Chyle contains chylomicrons from intestinal lymphatics and appears milky.

#### Causes {#s2150}

Tumor, 55% (especially lymphoma)Trauma, 25%•Iatrogenic duct laceration•Sharp, blunt traumaIdiopathic, 15%Rare causes•Lymphangioleiomyomatosis•Filariasis

Pleural tumors {#s2155}
--------------

### Fibrous tumor of the pleura {#s2160}

Unifocal tumor of the pleura. No relation to asbestos exposure. Fibrous tumors originate from visceral (70%) or parietal (30%) pleura, usually on a pedicle.

#### Clinical Findings {#s2165}

•Respiratory symptoms•HPO, 15%•Hypoglycemia, 5%

#### Types {#s2170}

•Benign, 80% (previously classified as benign mesothelioma)•Invasive, 20% (unlike malignant mesothelioma, this tumor grows only locally)

#### Radiographic Features {#s2175}

•Well-delineated, solitary pleural-based mass; often lobulated•Pedunculated, 30%; mass may flop into different locations from film to film.•Chest wall invasion may be seen in the invasive form, absent in benign form.•Tumor may grow in fissure and simulate the appearance of a solitary pulmonary nodule.•Recurrence rate after surgical resection, 10%•May have associated pleural effusion, necrosis

### Malignant mesothelioma {#s2180}

Incidence is 500 new cases/year in the United States. Risk is 300 times larger in asbestos workers than in general population. Highest rates are in Seattle (shipyard industry) and St. Louis. Twenty to 40 years between asbestos exposure and tumor development. Three histologic variants (diagnosis usually requires an open pleural biopsy):•Epithelial: difficult to differentiate from adenocarcinoma•Mesenchymal•Mixed

#### Radiographic Features ([Figs. 1-65](#f0330){ref-type="fig"} and [1-66](#f0335){ref-type="fig"}) {#s2185}

•Pleural thickening together with effusion, 60%Isolated pleural thickening, 25%Isolated pleural effusion, 15%•Hemithoracic contraction, 25%•Pleural calcification, 5%•CT best shows full extent of disease:Contralateral involvementChest wall and mediastinal involvement, 10%; diaphragm and abdominal extensionPericardial involvementPulmonary metastases•MRI useful to show chest wall or diaphragmatic extent Figure 1-65Figure 1-66

Other {#s2190}
-----

### Diaphragmatic paralysis {#s2195}

Paralysis of the diaphragm can be unilateral or bilateral.

#### Clinical Findings ([Fig. 1-67](#f0340){ref-type="fig"}) {#s2200}

•Unilateral paralysis is usually asymptomatic.•Bilateral paralysis results in respiratory symptoms. Figure 1-67

#### Causes {#s2205}

Phrenic nerve paralysis•Bronchogenic carcinoma•Neuropathies, postinfectious, nutritional•Spinal cord injury, myelitis•CNS injury: stroke•Cardiac surgery•Erb palsy (birth trauma)Muscular disorders•Myasthenia•Polymyositis•Muscular dystrophyIdiopathic, 70%

#### Radiographic Features {#s2210}

•Elevated hemidiaphragm•No motion of hemidiaphragm by fluoroscopy•Paradoxical motion of hemidiaphragm using "sniff test"•Reduced lung volume

Mediastinum {#s2215}
===========

General {#s2220}
-------

### Approach to mediastinal masses {#s2225}

•LocationAnterior mediastinumSuperior mediastinumMiddle mediastinumPosterior mediastinum•Invasive or noninvasive mass•Content: fat, cystic, solid, enhancement

Differentiation Between Mediastinal and Pulmonary MassesMediastinal MassPulmonary MassEpicenter in mediastinumEpicenter in lungObtuse angles with the lungAcute anglesNo air bronchogramsAir bronchograms possibleSmooth and sharp marginsIrregular marginsMovement with swallowingMovement with respirationBilateralUnilateral

### Normal variants causing a wide mediastinum {#s2230}

•Anteroposterior (AP) projection instead of posteroanterior (PA) projection•Mediastinal fat: obesity, steroid therapy•Vascular tortuosity: elderly patients•Low inspiratory supine position

Anterior mediastinal tumors {#s2235}
---------------------------

### Thymoma {#s2240}

Thymoma is the most common anterior mediastinal tumor in the adult (very rare in children). Thirty percent are invasive (malignant thymoma). Parathymic syndromes are present in 40% of patients:•35% of thymoma patients have myasthenia gravis (15% of myasthenia gravis patients have thymoma).•Aplastic anemia (50% have thymoma)•Hypogammaglobulinemia (15% have thymoma)•Red cell aplasia

#### Pathology {#s2245}

Benign thymoma, 75%•Common in patients with myastheniaMalignant thymoma, 25%•Local spread into pleura but no hematogenous metastases•More common in patients without myasthenia

#### Radiographic Features ([Fig. 1-68](#f0345){ref-type="fig"}) {#s2250}

•Anterior mediastinal soft tissue massAsymmetrical location on one sideHomogeneous density and signal intensitySome have cystic componentsContrast medium enhancement•Invasive thymomas show growth through capsule into adjacent tissue. Drop metastases into pleural space are common.•Calcifications, 20% Figure 1-68

### Thymolipoma {#s2255}

Thymolipomas are benign, encapsulated mediastinal tumors that contain both thymic and adipose tissue. The tumor occurs most frequently in children and young adults. Tumors usually grow to large sizes (75% are \>500 g) with few or no symptoms.

#### Associations {#s2260}

•Myasthenia gravis (in 3% of thymolipomas)•Aplastic anemia•Graves disease•Hypogammaglobulinemia•Lipomas in thyroid, pharynx

#### Radiographic Features {#s2265}

•Anterior mediastinal mass contains fatty and soft tissue elements.•The mass is usually large and displaces mediastinal structures and/or lungs.•Small tumors may be difficult to detect.•Large tumors mimic liposarcoma.

### Benign thymic hyperplasia {#s2270}

#### Causes {#s2275}

•Myasthenia•Thyrotoxicosis, Graves disease, Hashimoto thyroiditis•Collagen vascular diseases:SLESclerodermaRheumatoid arthritisBehçet disease•Rebound thymic hyperplasia:Chemotherapy (hyperplasia is often a good prognostic indicator)Addison diseaseAcromegaly

#### Radiographic Features {#s2280}

•Enlarged thymus without focal masses; fat interspersed in parenchyma•Size and morphology of normal thymus:\>20 years of age: \<13 mm\>30 years of age: convex margins are abnormal•No increase in size over time•If clinical suspicion for malignancy is high, a biopsy should be performed.

### Thyroid masses {#s2285}

Thyroid masses that extend into the mediastinum: goiter \> adenoma, carcinoma, lymphoma. Location of goiters within mediastinum:•Anterior to brachiocephalic vessels, 80%•Posterior to brachiocephalic vessels, 20%

#### Radiographic Features {#s2290}

Goiters•Thoracic inlet masses (thymomas are lower in the anterior mediastinum)•Mass is contiguous with cervical thyroid and is well defined.•Heterogeneous density by CT: calcium, iodine (70 to 120 HU), colloid cysts•Tracheal displacement is the most common finding by CXR.•CT: marked and prolonged contrast enhancement•Nuclear scan with either ^99m^Tc or ^123^I confirms the diagnosis (see Chapter 12).Other•Thyroid carcinoma has irregular borders.•Thyroid lymphomas generally show little enhancement.

### Germ cell tumors {#s2295}

Tumors arise from rests of primitive cells and are of variable malignant potential. Mnemonic: "SECTE":•**S**eminoma•**E**mbryonal cell carcinoma•**C**horiocarcinoma•**T**eratoma (70% of germ cell tumors), teratocarcinoma•**E**ndodermal sinus tumors (yolk sac tumors)

#### Teratoma ([Fig. 1-69](#f0350){ref-type="fig"}) {#s2300}

•20% are malignant; therefore all mediastinal teratomas should be surgically removed.•Teratomas typically present as large mass lesions.•Variable tissue contents:Calcification, 30%Fat, fat-fluid levelsCystic areasSoft tissue Figure 1-69

#### Seminoma {#s2305}

•Rarely infiltrative•Large, unencapsulated lesions•Occasionally associated with testicular atrophy

#### Embryonal Cell Carcinoma {#s2310}

•Mediastinal invasion is the rule: poor prognosis (mean survival time \<10 months).•Elevated AFP and human chorionic gonadotropin (HCG)

### Hodgkin lymphoma {#s2315}

The pathologic diagnosis is based on the presence of Reed-Sternberg cells. The cell of origin is the antigen-presenting interdigitating cells in the paracortical regions of the lymph node (not B or T cells). Ninety percent originate in the lymph nodes; 10% originate in extranodal lymphoid tissues of parenchymal organs (lung, GI tract, skin). Incidence is 1:50,000. Bimodal age distribution with peaks at 30 and 70 years.

Types of Hodgkin LymphomaTypeFrequencyPrognosisLymphocyte predominant (LP)\<5% (young patients)Most favorableNodular sclerosing (NS)70%Less favorable than LPMixed cellularity (MC)25% (old patients)Less favorable than NSLymphocyte depleted (LD)\<5%Worst prognosis Staging (ANN ARBOR)Stage[\*](#tf0020){ref-type="table-fn"}InvolvementISingle node group or regionIESingle extranodal siteIITwo or more nodes on same side of diaphragmIIELocalized disease in an organ and node on same side of diaphragmIIINode groups on both sides of diaphragmIIIEAbove diaphragm + localized extralymphaticIIISAbove diaphragm + spleenIVExtension beyond above limit[^6]

#### Radiographic Features ([Fig. 1-70](#f0355){ref-type="fig"}) {#s2320}

•Superior mediastinal nodal (prevascular, paratracheal) involvement, 95%•Contiguous progression from one lymph node group to the next•Lung involvement, 15%Pulmonary mass lesion, air bronchogramsDirect extension into lung from involved nodes (most common)•Pleural effusions, 15%•Posttherapeutic mediastinal changes commonThymic cystsThymic hyperplasiaPersistent mediastinal masses may be present without representing active disease: ^67^Ga, PET scanning may be helpful for differentiation. Figure 1-70

#### Pearls {#s2325}

•Recurrence of lymphomaRadiation treatment: recurrence usually occurs outside the treatment field (commonly paracardiac region).No radiation: recurrence usually in sites of previous involvement•5% of treated Hodgkin patients will develop aggressive leukemias•Radiation pneumonitis occurs 6 to 8 weeks after completion of the radiation and evolves to mature fibrosis by 1 year.

### Non-hodgkin lymphoma (NHL) {#s2330}

Sixty percent of cases originate in lymph nodes and 40% in extranodal sites. Eighty-five percent arise from B cells and 15% from T cells. Occurs in all age groups (mean age, 50 years). Increased incidence in patients with altered immune status:•Transplant patients•AIDS•Congenital immunodeficiency•Collagen vascular diseases: RA, SLEClassifications of Non-Hodgkin Lymphoma[\*](#tf0025){ref-type="table-fn"}Working FormulationRappaportCommentLow GradeSmall, lymphocyticLymphocytic, well differentiatedUncommonFollicular, small cleavedNodular, poorly differentiatedMost frequent typeFollicular, mixed cellsNodular, mixedIntermediate GradeFollicular, large cellsNodular, histiocyticDiffuse, small cleavedDiffuse, lymphocyticDiffuse, mixed cellDiffuse, mixedDiffuse, large cellDiffuse, histiocyticGI involvement, 25%High GradeImmunoblasticDiffuse, histiocyticGI involvement, 25%LymphoblasticLymphoblasticMediastinal mass, young patientSmall, noncleavedDiffuse undifferentiated (Burkitt and non-Burkitt)Abdominal form (North America), craniofacial (Africa)[^7]

#### Radiographic Features {#s2335}

Mediastinal and hilar adenopathy•Often generalized at presentation•Adenopathy may be noncontiguous.Lung involvement•May occur without adenopathy•Patterns: mass, chronic ASDExtrathoracic spread•Nasooropharynx•GI tract•Spread to unusual sites common

Middle mediastinal tumors {#s2340}
-------------------------

### Bronchopulmonary foregut malformations ([Fig. 1-71](#f0360){ref-type="fig"}) {#s2345}

Abnormalities in budding and differentiation of the primitive foregut. Depending on type, duplication cysts are also classified as posterior mediastinal masses. The lining of the cyst wall determines the cyst type:•Bronchogenic cysts: ventral defects containing respiratory epithelium•Enteric cysts: posterior defects containing gastrointestinal epithelium (gastric mucosa \> esophageal mucosa \> small bowel mucosa \> pancreatic tissue)Differentiation Between Bronchogenic and Enteric CystsBronchogenic CystEnteric CystLocationVentralDorsalLevelSubcarinalSupracarinalCyst wallImperceptibleThick wallSymptomsAsymptomatic unless there is mass effect; usually as an incidental findingSymptomatic: peptic ulceration, distentionOther imaging findingsMay contain calcificationVertebral body anomaliesAssociated rib anomaliesHemivertebraCT: no contrast enhancementScoliosisT2 hypointenseSpina bifida Figure 1-71

#### Radiographic Features ([Fig. 1-72](#f0365){ref-type="fig"}) {#s2350}

•Round mass of water/protein density•LocationBronchogenic cysts are mediastinal (75%) or pulmonary (25%). Mediastinal locations: subcarinal, 50%; paratracheal, 20%; hilar, paracardiac, 30%. Esophageal duplication cysts are located along the course of the esophagus.•High CT density (40%) may be due to debris, hemorrhage, infection•Calcifications in wall (rare finding) Figure 1-72

### Castleman disease (giant benign lymph node hyperplasia) {#s2355}

Large, benign mediastinal lymph node masses. Rare. Etiology is unknown (nodal hyperplasia vs. benign tumor). Two histologic types: hyaline vascular, 90%; plasma cell, 10% (associated with general symptoms: night sweats, fever, etc.). Age \<30 years, 70%. Treatment is surgical excision. Includes hyaline vascular and plasma cell types.

#### Radiographic Features {#s2360}

•Bulky mediastinal mass lesion (3 to 12 cm): anterior \> middle \> posterior mediastinum•Dense homogeneous contrast enhancement is the key feature ("vascular lesions")•Nodal calcification may be present.•Involvement of lymph nodes in neck, axillae, and pelvis is rare.•Slow growth

### Fibrosing mediastinitis {#s2365}

Cause is mediastinal histoplasmosis; may be idiopathic. May result in obstruction of pulmonary artery, veins, bronchi. Calcified lymph nodes.

Posterior mediastinal tumors {#s2370}
----------------------------

### Neural tumors {#s2375}

Posterior mediastinal neural tumors arise from:Peripheral nerves, 45% benign•Schwannoma (arise from nerve sheath)•Neurofibroma (contain all elements of nerve)Sympathetic ganglia (varying malignant potential)•Ganglioneuroma (benign)•Ganglioneuroblastoma•Neuroblastoma (malignant)Paraganglion cells, 2%•Paraganglioma (chemodectoma, histologically similar to pheochromocytoma): functional tumors, may secrete catecholamines. Intense contrast enhancement. Found in AP window.

#### Radiographic Features ([Fig. 1-73](#f0370){ref-type="fig"}) {#s2380}

Schwannoma, neurofibroma•Arise posteriorly, frequently in neural foramina•May cause widening and erosion of neural foramina•Usually round or oval and \<2 vertebral bodies long•Enhancement with contrast•T2-weighted (T2W) very hyperintenseSympathetic ganglia tumors•Arise anterolaterally (more conspicuous on plain film)•Usually elongated and fusiform (resembling sympathetic chain) and \>2 vertebral bodies long Figure 1-73

### Extramedullary hematopoiesis {#s2385}

Paravertebral masses represent bone marrow extruded through cortical defects of vertebral bodies. Seen in congenital anemias (e.g., thalassemia). Suspect diagnosis if:•Multiple bilateral posterior mediastinal masses•Cortical bone changes by CT•Clinical history of anemia•Marked contrast enhancement

Other mediastinal disorders {#s2390}
---------------------------

### Pneumomediastinum {#s2395}

Sources of mediastinal air:Intrathoracic•Trachea and major bronchi•Esophagus•Lung•Pleural spaceExtrathoracic•Head and neck•Intraperitoneum and retroperitoneum

#### Radiographic Features {#s2400}

•Subcutaneous emphysema•Elevated thymus: thymic sail sign•Air anterior to pericardium: pneumopericardium•Air around pulmonary artery and main branches: ring around artery sign•Air outlining major aortic branches: tubular artery sign•Air outlining bronchial wall: double bronchial wall sign•Continuous diaphragm sign: due to air trapped posterior to pericardium•Air between parietal pleura and diaphragm: extrapleural sign•Air in pulmonary ligament

Differential Diagnosis {#s2405}
======================

General {#s2410}
-------

### Approach to CXR ([Fig. 1-74](#f0375){ref-type="fig"}) {#s2415}

1.Lungs•Focal or diffuse abnormalities•Lung volumesIncreased or decreasedRight/left difference in density•Hypolucent areas2.Trachea and bronchi3.Mediastinal lines•Paratracheal stripe•AP window•Azygoesophageal recess•Paraspinal lines•Other linesAnterior and posterior junction linePosterior wall of intermediate bronchus4.Hila and cardiac contour5.Pleura, fissures6.Bones•Focal metastases•Rib notching•Clavicles Figure 1-74

### Approach to ICU films {#s2420}

1.Lines (check position)2.Pneumothorax, pneumomediastinum3.Focal parenchymal opacities•Atelectasis•Pneumonia•Aspiration•Hemorrhage•Contusion4.Diffuse parenchymal opacities•ARDS•Pneumonia•Edema•Less common:AspirationHemorrhage

### Directed search in apparently normal chest films {#s2425}

Lungs•Hidden nodules•Subtle interstitial disease•Differences in lung density•Retrocardiac disease•Bronchiectasis•Pulmonary embolismMediastinum•Posterior mediastinal mass•Tracheal lesions, deviation•Subtle hilar mass lesionsBones•Lytic, sclerotic lesions•Rib notching

### Generic approaches to film interpretation {#s2430}

#### The "4 Ds" {#s2435}

•Detection•Description•Differential diagnosis•Decision about management

#### Lesion Description {#s2440}

•Location•Extent•CharacteristicsSignal intensity, density, echogenicity, etc.Behavior after administration of contrast material•Differential diagnosis

### Universal differential diagnosis {#s2445}

Mnemonic: "TIC MTV:"•**T**umor•**I**nflammationInfectiousNoninfectious causes•**C**ongenital•**M**etabolic•**T**rauma, iatrogenic•**V**ascular

Atelectasis {#s2450}
-----------

### Lobar, segmental atelectasis ([Fig. 1-75](#f0380){ref-type="fig"}) {#s2455}

Endobronchial lesionExtrinsic bronchial compression•Tumor•LymphadenopathyMalignantBenign adenopathy (i.e., sarcoid rarely causes lobar collapse\])Rare causesBronchial torsion Figure 1-75

### Signs of lobar atelectasis {#s2460}

Direct signs•Displacement of interlobar fissures (lobar collapse)•Increase in opacity of the involved segment or lobeIndirect signs•Displacement of hila•Mediastinal displacement•Elevation of hemidiaphragm•Overinflation of remaining normal lung•Approximation of ribs

#### RUL Collapse ([Figure 1-76](#f0385){ref-type="fig"}, [Figure 1-77](#f0390){ref-type="fig"}) {#s2465}

•Elevation of minor fissure•Shift of trachea to right•Elevation of hilum•Thickening of right paratracheal in complete collapse Figure 1-76Figure 1-77

#### RML Collapse {#s2470}

•Best seen on lordotic views•RML syndrome: recurrent atelectasis despite an open orifice:Absent collateral ventilationBronchus is surrounded by enlarged lymph nodes (TB)May have coexistent bronchiectasis

#### RLL Collapse ([Fig. 1-78](#f0395){ref-type="fig"}) {#s2475}

•Triangular opacity in right retrocardiac region on PA film with obliteration of diaphragm•Posterior displacement of right margin•Opacity over the spine Figure 1-78

#### LUL Collapse ([Fig. 1-79](#f0400){ref-type="fig"}) {#s2480}

•May be difficult to see: hazy density can be easily confused with loculated pleural effusion on PA film•"Luftsichel": radiolucency in upper lung zone that results from upward migration of superior segment of the left lower lobe (LLL)•Anterior displacement of major fissure on lateral view Figure 1-79

#### LLL Collapse ([Fig. 1-80](#f0405){ref-type="fig"}) {#s2485}

•Left retrocardiac triangular opacity on PA film•Posterior displacement of left major fissure on lateral film Figure 1-80

#### CT Findings of Lobar Collapse ([Figs. 1-81](#f0410){ref-type="fig"}) {#s2490}

•Increased density of collapsed lobe•See figure for patterns. Figure 1-81

### Types of peripheral atelectasis {#s2495}

Relaxation•Pleural effusion•Pneumothorax•Bullous diseaseAtelectasis associated with fibrosis•Granulomatous infections•Pneumoconiosis•SarcoidResorptive atelectasis secondary to obstruction•Platelike, discoid atelectasisDepletion of surfactant (adhesive atelectasis; airways patent)•ARDS of the newborn•Radiation injuryRounded atelectasis•Due to pleural disease

Consolidation {#s2500}
-------------

###  {#s2905}

#### Radiographic Features ([Figs. 1-82](#f0415){ref-type="fig"} and [1-83](#f0420){ref-type="fig"}) {#s2505}

Acinar shadow•Air in acini (7 mm in diameter) is replaced by fluid or tissue•May be confluence to form patchy densitiesAir bronchogram•Represents aerated airways in consolidated lung•Air bronchogram may also be seen in some forms of collapse.Absence of volume loss•No displaced fissures•No elevation of diaphragmNonsegmental distribution•Intersegmental spread is common because channels of interalveolar communication (channels of collateral drift) allow passage of air and fluid•Channels of collateral drift include:Pores of Kohn (interalveolar openings)Channels of Lambert (bronchioalveolar communications)Direct airway anastomosis, 120 μm in diameter Figure 1-82Figure 1-83

### Causes of consolidation {#s2510}

#### Fluid in Acini {#s2515}

Water (edema)•Cardiac pulmonary edema•Renal pulmonary edema•Lung injury, pulmonary edemaBlood•Trauma (most common)•Bleeding disorder: anticoagulation, etc.•Type II antigen-antibody reaction•Goodpasture syndrome•Henoch-Schönlein purpura•Pulmonary infarct (Hampton hump)•VasculitisProteinaceous fluid•Alveolar proteinosis

#### Inflammatory Exudate in Acini {#s2520}

Infection•Bacterial infections (pus)•*Nocardia,* actinomycosis, TBNoninfectious•Allergic hypersensitivity alveolitis•Chronic eosinophilic pneumonia•COP•Pulmonary infiltration with eosinophiliaLoeffler syndromeChronic eosinophilic pneumoniaPneumonitisABPADrugs: penicillin•Aspiration of lipid material•Sarcoid (resides only in interstitial space but encroaches on airspace to produce a pattern that mimics ASD)

#### Tumor in Acini {#s2525}

Bronchioalveolar carcinomaLymphoma

### Pulmonary renal syndromes {#s2530}

These syndromes are characterized by pulmonary hemorrhage and nephritis.

Pulmonary findings usually present as consolidation on CXR.•Goodpasture syndrome (anti-GBM positive)•Wegener disease (ANCA positive; nodules are more common than ASD)•SLE•Henoch-Schönlein purpura•Polyarteritis nodosa•Penicillamine hypersensitivity

### Acute respiratory distress syndrome (ARDS) {#s2535}

Clinical syndrome characterized by sudden onset of triad:•Respiratory distress•Hypoxemia•Opaque, stiff lungs

After an incipient catastrophic event, mediators of injury are activated → inflammatory response → endothelial damage → injury, pulmonary edema (ARDS): ARDS runs independent course from initiating disease.

#### Radiographic Features {#s2540}

•Diffuse alveolar consolidation, commonly indistinguishable from pneumonia or pulmonary edema•End stage•Interstitial fibrosis and scarring

#### Causes {#s2545}

•Massive pneumonia•Trauma•Shock•Sepsis•Pancreatitis•Drug overdose•Near-drowning•Aspiration

### Chronic airspace disease {#s2550}

Tumors•Bronchioalveolar carcinoma•LymphomaInflammation•Tuberculosis, fungus•Eosinophilic pneumonia•Pneumonitis, BOOP/COP•Alveolar sarcoid (mimics ASD)Other causes•Alveolar proteinosis•Pulmonary hemorrhage•Lipoid pneumonia, chronic aspiration

Pulmonary masses {#s2555}
----------------

### Approach to solitary pulmonary nodule ([Fig. 1-84](#f0425){ref-type="fig"}) {#s2560}

Differentiation Between Benign and Malignant NodulesBenignMalignantShapeRoundIrregularSize\<3 cm\>3 cmSpiculationsNoYesEdgeWell definedIll definedSatellite lesionsYesNoCavitationNoYesDoubling time (in volume)\<1 month or \>2 years\>1 month or \<2 years Figure 1-84

The above-listed criteria *do not* allow reliable differentiation of a solitary pulmonary nodule. There are only *three* criteria by which a solitary pulmonary nodule can be judged benign:•Fat density•Specific types of benign calcifications (diffuse, central, popcorn, concentric):\>10% of a nodule consists of calcium with HU \>200Large or homogeneous calcification throughout nodule (exceptions: multiple metastases from osteosarcoma, thyroid carcinoma, etc.)•Old films show no interval growth within a 2-year period

#### CT Workup {#s2575}

\<4 mm: 99% benign if no known primary tumor•Follow-up CT in 12 and 24 months; if no growth after 24 months, nodule is assumed benign.•Follow-up CT in 3, 6, 12, and 24 months if clinical suspicion.\<4 to 8 mm: 94% benign if no known primary•Follow-up at 3, 6, 12, and 24 months•Consider PET or biopsy if high clinical suspicion\>8 mm: 50% malignant•Percutaneous biopsy•Other options: PET and surgical removal (VATS)

#### Pearls {#s2580}

•Always get a second imaging modality (CT \> MR \> angiogram) before sampling a solitary pulmonary nodule to exclude AV malformations. However, remember that 97% of all solitary nodules are either granulomas or primary carcinomas.•Extrapulmonary densities may mimic pulmonary lesions.Artifact (nipple, skin, electrodes)Pseudotumor (fluid in fissure)Pleural mass or plaqueRib fracture•Solitary pulmonary metastases seen on CXR will be truly solitary in only 50% of the cases.•Any solitary pulmonary nodule in cancer patients requires further workup:Comparison with old filmsPercutaneous biopsy if large enoughClose follow-up (usually 3-month intervals)•HRCT for nodule densitometryPerform only in nodules \<3.0 cm in diameter.Densities of \>200 HU indicate presence of calcification.

### Hidden zones ([Fig. 1-85](#f0430){ref-type="fig"}) {#s2585}

Subtle pulmonary nodules are often missed if \<3 cm and located in:•Upper lobes (apices)•Central, paramediastinal•Superimposed onto ribs and clavicle Figure 1-85

An effort should be made to perform a directed search in these regions to detect subtle lung cancer. This zone has also been called the lawyer zone. The threshold of lesion detection by plain film is approximately 9 mm.

### Solitary nodule {#s2590}

Criteria: \<6 cm. May be smooth, lobulated, discrete, circumscribed, calcified, cavitated, or have satellite lesions.Tumor (45%)•Primary carcinoma, 70%•Hamartoma, 15%•Solitary metastasis, 10%Inflammation (53%); regional variations•Histoplasmoma•Tuberculoma•CoccidioidomycosisOther (2%)•Vascular, 15%AV fistulaPulmonary varix (dilated pulmonary vein)Infarct, embolism•Congenital, 30%SequestrationBronchial cyst•Miscellaneous, 45%Round pneumoniaLoculated effusion in fissureMucus plugEnlarged subpleural lymph nodeSilicosis (usually multiple nodules)

### Multiple nodules {#s2595}

Multiplicity of pulmonary nodules often indicates hematogenous dissemination.

#### Causes {#s2600}

MetastasesAbscess•Pyogenic: *Staphylococcus \> Klebsiella \> Streptococcus*•Immunocompromised patient: *Nocardia, Legionella*Granulomatous lung diseases•InfectiousTBFungus: *Aspergillus, Histoplasma*•NoninfectiousSarcoidRheumatoid nodulesSilicosisWegener diseaseNecrotizing granulomatous vasculitisHistiocytosisUnilateral pulmonary embolism

### Miliary pattern ([Fig. 1-86](#f0435){ref-type="fig"}) {#s2605}

Special pattern of multiple pulmonary nodules characterized by small size and diffuse bilateral distribution (too numerous to count). If the nodules are small enough, also consider the differential diagnosis for nodular interstitial disease.Figure 1-86

#### Causes {#s2610}

•Hematogenous infection: TB, histoplasmosis•Hematogenous tumor seeding:Metastases: thyroid, melanoma, breast, choriocarcinomaEosinophilic granulomaBronchioalveolar cancer•Silicosis•Sarcoid

### Calcified lung nodules {#s2615}

Larger (\>1 mm)•TumorMetastases from medullary thyroid cancerMucinous or osteogenic metastases•InfectionPrevious varicella pneumoniaHistoplasmosis, coccidioidomycosis, TBParasites: schistosomiasis•OtherSilicosis, CWPVery small (0.1 to 1 mm; sandlike)•Alveolar microlithiasis•Chronic pulmonary venous hypertension•"Metastatic" calcification from severe renal disease

### Large (\>6 CM) thoracic mass {#s2620}

Pulmonary•TumorBronchogenic carcinomaMetastases (SCC from head and neck)•Abscess•Round atelectasis•Intrapulmonary sequestration•Hydatid diseaseExtrapulmonary•Fibrous tumor of the pleura•Loculated pleural effusion•Torsed pulmonary lobe•Chest wall tumors (Askin tumor)•AAA•Mediastinal masses

### Upper lung zone opacities with calcified adenopathy {#s2625}

•Silicosis•Sarcoidosis•Berylliosis•CWP•TB

### Infection that can cause chest wall invasion {#s2630}

•*Actinomyces*•*Nocardia*•TB•*Blastomyces*•*Aspergillus*•*Mucor*

### Infection with lymphadenopathy {#s2635}

•TB•Histoplasmosis (fungal)•EBV (viral)

Cystic and cavitary lesions ([Fig. 1-87](#f0440){ref-type="fig"}) {#s2640}
-----------------------------------------------------------------

### Approach {#s2645}

The wall thickness and morphology are helpful (but not definitive) to determine if a cavitary lesion is benign or malignant.Thickness (not always reliable)•\<2 mm, benign in 95%•2 to 15 mm, malignant in 50%•\>15 mm, malignant in \>95%Morphology (not reliable)Eccentric cavity: suggests malignancy•Shaggy internal margins: suggests malignancy Figure 1-87

### Cysts ([Figs. 1-88](#f0445){ref-type="fig"} and [1-89](#f0450){ref-type="fig"}) {#s2650}

Parenchyma-lined space, filled with air or fluid•Pneumatocele (posttraumatic, postinfectious): common•Bulla (located within lung parenchyma), bleb (located within the nine histologic layers of the visceral pleura)•Cystic bronchiectasis•Langerhans cell histiocytosis•Lymphocytic interstitial pneumonia•Lymphangioleiomyomatosis•Metastases•Neurofibromatosis type 1•Tracheobronchial papillomatosis•*Pneumocystis jiroveci* pneumonia•Congenital cystsIntrapulmonary bronchogenic cysts (rib and vertebral body anomalies common)Cystic adenomatoid malformation (multiple lesions)Sequestration•Hydatid cyst (onion skin appearance) Figure 1-88Figure 1-89

### Cavity {#s2655}

Parenchymal necrosis due to inflammation (benign) or tumor (malignant)Abscess•Pyogenic: *Staphylococcus \> Klebsiella \> Streptococcus*•Immunocompromised patient: *Nocardia, Legionella*Cavitated tumor•SCC (primary SCC \> head and neck SCC \> sarcoma metastases)•Sarcoma•Lymphoma•TCC of the bladderCavitated granulomatous mass (often multiple)•Fungus: *Aspergillus,* coccidioidomycosis (thin wall)•TB•Sarcoid, Wegener disease, rheumatoid nodules•Necrotizing granulomatous vasculitisCavitated posttraumatic hematoma

### Air crescent sign in cavity {#s2660}

This sign was originally described in aspergillosis and is most commonly seen there.

More recently, the sign has also been described with other entities:•Mucormycosis•Actinomycosis•Septic emboli•*Klebsiella pneumoniae* infection•TB•Tumors

### Small cystic disease ([Fig. 1-90](#f0455){ref-type="fig"}) {#s2665}

True cyst wall•Eosinophilic granuloma•Lymphangioleiomyomatosis•Cystic form of PCP•Honeycombing in any end-stage interstitial disease•LIPNo cyst wall•Emphysema Figure 1-90

Interstitial lung disease {#s2670}
-------------------------

### Radiographic patterns of interstitial disease {#s2675}

#### Types of Densities {#s2680}

•Linear or reticular densities: thickened interlobular septa, fibrosis•Reticulonodular densities: inflammation in peribronchovascular interstitium•Nodular densities: granulomas•Ground-glass opacity: usually represents acute interstitial disease (occasionally seen with chronic fibrosis)Hazy increase in lung densityVessels can be clearly seen through haze•Honeycombing: ring shadows 2 to 10 mm; end-stage lung disease

#### Kerley Lines (Linear Densities) ([Fig. 1-91](#f0460){ref-type="fig"}) {#s2685}

Kerley B lines, peripherally located in interlobular septa:•\<2 cm long•Peripheral•Perpendicular to pleuraKerley A lines:•2 to 6 cm long•Central•No relationship to bronchioarterial bundlesKerley C lines•Fine network caused by superimposition of Kerley B lines Figure 1-91

### Approach {#s2690}

Define the following parameters:•Type of pattern•Distribution•Lung volumes•Evolution•Pleural disease•Lymph nodes

#### Generic Approach {#s2695}

Interstitial disease is due to thickening of interlobular septa (lymphatics, veins, or infiltration by cells), alveolar walls, and interstitium. Causes of thickening includeFluid•WaterPulmonary edemaVenous obstruction (thrombosis)•Proteinaceous materialCongenital pulmonary lymphangiectasia (very rare)Inflammation•Infectious (interstitial pneumonias)ViralGranulomatous (TB, fungal)PCP•IdiopathicIPFSarcoid•Collagen vascular diseaseRASclerodermaAnkylosing spondylitis•Extrinsic agentsPneumoconiosis (asbestos, silicosis, CWP)DrugsTumor•Interstitial tumorsEosinophilic granuloma•Lymphangitic tumor spread•Desmoplastic reaction to tumorMnemonic Approach to Differential DiagnosisExamples of Common EntitiesDistributionUpper lobes ("CASSET P")**C**ystic fibrosis (not an interstitial disease)**A**nkylosing spondylitis**S**ilicosis**S**arcoid**E**osinophilic granuloma (sparing of costophrenic angles)**T**uberculosis***P****neumocystis carinii*Lower lobes ("BADAS")**B**ronchiectasis (not an interstitial disease)**A**spiration**D**rugs, DIP**A**sbestosis**S**cleroderma, other collagen vascular diseasesEvolutionAcute ("HELP")**H**ypersensitivity (allergic alveolitis)**E**dema**L**ymphoproliferative**P**neumonitis, viralChronic ("LIFE")**L**ymphangitic spread**I**nflammation, infection**F**ibrosis**E**demaLung VolumesIncreasedCystic fibrosis (associated with this pattern but not an interstitial disease)Eosinophilic granuloma (pneumothorax, 20%)Lymphangioleiomyomatosis (pneumothorax)DecreasedIdiopathic pulmonary fibrosisSclerodermaPleural DiseasePleural plaquesAsbestosisPleural effusionCHFLymphangitic carcinomatosisRheumatoid diseaseLymph NodesEnlargedMalignant adenopathyTB, fungusSarcoidCalcifiedSilicosis HRCT Patterns of Interstitial Lung DiseaseImagingCausesGround-Glass OpacityIncreased hazeAll acute interstitial diseases![](u01-15-9780323065382.gif)Allergic hypersensitivityAll acute interstitial diseaseDIPActive IPFViralPCPBOOP/COPEosinophilic pneumoniaPulmonary edemaReticulonodular OpacitiesPeribronchovascular thickening (peribronchial cuffing on CXR)Thickening of interlobular septa (Kerley lines)![](u01-16-9780323065382.gif)Pulmonary edemaViral, mycoplasmal pneumonia, and PCPLymphangitic tumor spreadPulmonary fibrosisIPFSecondary fibrosisDrugsRadiationCollagen vascular diseaseHemosiderosisAsbestosisNodular Opacities1- to 2-mm interstitial nodules![](u01-17-9780323065382.gif)Hematogenous infectionOften associated with reticular opacitiesHematogenous metastasesSarcoidPneumoconiosisSilicosisCWPHistiocytosis (EG, also cysts)Cystic SpacesWith or without walls![](u01-18-9780323065382.gif)LymphangioleiomyomatosisCystic PCPHistiocytosisHoneycombingIPF\
LIPAny end-stage interstitial disease

### Crazy-paving appearance on HRCT {#s2700}

Ground-glass opacity with overlying geometric structures formed by thickened interlobular septa and intraseptal lines•Pulmonary alveolar proteinosis•ARDS•PCP•Lipoid pneumonia•Hemorrhage•Bronchoalveolar carcinoma (BAC)•Pulmonary edema

### Pulmonary hemorrhage {#s2705}

Focal•PE•Trauma (contusion)•AVM•Cancer (BAC)Diffuse•Wegener•Goodpasture (resolves in days to weeks, can result in fibrosis)•Idiopathic (children)•Bone marrow transplant

### Halo pattern of ground-glass opacity {#s2710}

•Early invasive aspergillosis in a leukemic patient: ground glass around a nodule of consolidation•Hemorrhage around a neoplasm•Postbiopsy pseudonodule

### Peripheral ground-glass opacity and consolidation {#s2715}

•COP•Infarcts•Septic emboli•Collagen vascular disease•Contusion•DIP•Drug toxicity•Eosinophilic pneumonia•Fibrosis•Sarcoidosis

### Honeycombing pattern on HRCT {#s2720}

•UIP (idiopathic pulmonary fibrosis)•Scleroderma/RA•Asbestosis•Chronic hypersensitivity pneumonitis•Sarcoidosis•Silicosis•EG•Drug toxicity: bleomycin

### Diseases spreading along bronchovascular bundle {#s2725}

•Sarcoidosis•Lymphoma•Lymphangitic spread of tumor•TB•Kaposi sarcoma

### Tree-in-bud appearance {#s2730}

Infection•TB•Bronchopneumonia•Fungal•Asian panbronchiolitis•Viral pneumoniasBronchial disease•BronchiolitisCongenital disorders•Cystic fibrosis•Dyskinetic cilia syndromeOther•Allergic bronchopulmonary aspergillosis•Lymphangitic carcinomatosis•EG

Abnormal density {#s2735}
----------------

### Hyperlucent lung {#s2740}

Hyperlucency may be lobar, segmental, subsegmental, or generalized. Hyperlucency may or may not be associated with overexpansion of lungs.

#### Causes {#s2745}

Airways•Obstruction of airways (air trapping); inspiratory/expiratory films may be of use to accentuate the hyperlucencyEmphysema, bullaeLarge airway obstruction: asthma, mucus plugSmall airway obstruction (bronchioli): Swyer-James syndrome (bronchiolitis obliterans)Compensatory hyperexpansion of residual lung after: surgical lobectomy, chronic lobar collapse•Cysts•CongenitalHypogenetic lung syndromeCongenital lobar emphysemaVascular (hyperlucency caused by oligemia)•PE•Pulmonary artery stenosisChest wall abnormalities•Mastectomy•Poland syndrome (congenital absence of pectoralis muscle)Pleural•Pneumothorax

### Small lung ([Fig. 1-92](#f0465){ref-type="fig"}) {#s2750}

May be associated with either decreased or increased density•Hypogenetic lung syndrome•Agenesis of pulmonary artery•Chronic atelectasis•Bronchiolitis obliterans (Swyer-James syndrome) Figure 1-92

Tracheobronchial lesions {#s2755}
------------------------

### Endobronchial lesions {#s2760}

Focal bronchial abnormality

#### Causes {#s2765}

Tumors, 80%•Malignancy, 70%:SCC (most common)Low-grade malignanciesAdenocystic carcinomaMucoepidermoid carcinomaSmall cell carcinomaCarcinoid•Metastases, 5%: RCC, melanoma, colon, breast, thyroid•Other: hamartoma, mucoepidermoid carcinoma, hemangiomaInflammatory disease, 20%•TBOther•Mucus plug•Foreign body (fishbone, dental)•Trauma•Broncholith

### Diffuse tracheal luminal abnormalities {#s2770}

Increased diameter•Tracheobronchomegaly (Mounier-Kuhn syndrome)•Pulmonary fibrosis•TracheomalaciaDecreased diameter•Saber-sheath trachea (most common cause)•Tracheopathia osteochondroplastica•Tracheomalacia (decreased diameter on expiration)•Relapsing polychondritis•Amyloidosis•Sarcoidosis•Wegener disease•Tuberculous and fungal stenosis

### Bronchiectasis {#s2775}

Postinfectious (most common)•Any childhood infection•Recurrent aspiration•ABPA: central bronchiectasis•Chronic granulomatous infection•PertussisBronchial obstruction•Neoplasm•Foreign bodyCongenital•Cystic fibrosis (abnormal secretions)•Bronchial cartilage deficiency: Williams-Campbell syndrome•Abnormal mucociliary transport: Kartagener syndrome

### Upper lobe bronchiectasis ([Fig. 1-93](#f0470){ref-type="fig"}) {#s2780}

•Cystic fibrosis•TB•Radiation•ABPA (most commonly central)•Mounier-Kuhn syndrome•Agammaglobulinemia•Kartagener syndrome Figure 1-93

### Mucoid (bronchial) impaction {#s2785}

Criteria: bronchus filled with soft tissue density (inspissated mucus); bronchi may be enlarged (bronchocele) or of normal size. No contrast enhancement.

#### Causes {#s2790}

•Asthma•Cystic fibrosis•ABPA•Congenital bronchial atresia

Pleural disease {#s2795}
---------------

### Pleural-based mass ([Fig. 1-94](#f0475){ref-type="fig"}) {#s2800}

Soft tissue mass along the chest wall; obtuse angles with chest wall.Tumor•Mesothelioma (malignant): multifocal, diffuse•Fibrous tumor of the pleura (benign); unifocal may be locally invasive•Malignant thymoma and lymphoma often have appearance similar to that of mesothelioma•Metastases: breast, lung, prostate, thyroid, renal•Lipoma (most common benign tumor)•Extrapleural tumorsRib tumorsChildren: EG, ABC, Ewing sarcoma, neuroblastomaAdults: metastases \> multiple myeloma \> Paget disease, fibrous dysplasiaPlexiform neurofibromas in neurofibromatosis (bilateral)Inflammatory•Infectious: TB•Asbestos related•Actinomycosis (rib destruction)Trauma, surgery, chest tubes Figure 1-94

### Calcified pleural plaques {#s2805}

The most common causes of calcified pleural plaques (mnemonic: "TAFT") are:•**T**uberculosis (usually diffuse plaques)•**A**sbestos-related plaques (usually focal plaques)•**F**luid (empyema, hematoma)•**T**alc

### Elevated hemidiaphragm ([Fig. 1-95](#f0480){ref-type="fig"}) {#s2810}

Phrenic nerve paralysis•Tumor•Surgery•Birth defect: Erb paralysisImmobility because of pain•Rib fractures•Pleuritis, pneumonia•PE•Mass lesions•Abdominal masses, subphrenic collection, abscess•Diaphragmatic hernia•Pleural tumors•Subpulmonic effusion (apparent elevation of hemidiaphragm) Figure 1-95

Mediastinum {#s2815}
-----------

### Anterior mediastinal masses ([Fig. 1-96](#f0485){ref-type="fig"}) {#s2820}

Thymic masses•Thymic cyst•Thymolipoma•ThymomaCysticBenign (noninvasive) thymomaMalignant (invasive) thymoma•Thymic carcinoma•Thymic carcinoid•Thymic lymphomaGerm cell tumors (male \> female)•Seminoma•Embryonal cell carcinoma•Choriocarcinoma•TeratomaLymphadenopathy: lymphoma, sarcoid, TB, etc.Aneurysm and vascular abnormalities (involve both the anterior and superior mediastinal compartments)Mnemonic for anterior mediastinal masses: the "4 Ts":•Thymoma (most common anterior mediastinal mass) + other thymic lesions•Thyroid lesions•T-cell lymphoma (Hodgkin disease and NHL)•Teratoma and other germ cell tumors (seminoma, choriocarcinoma), 10% Figure 1-96

#### Cystic Anterior Mediastinal Mass {#s2825}

•Thymic cyst (3rd pharyngeal pouch remnant)•Cystic thymoma (contains solid components besides cysts)•Teratoma•Bronchogenic cysts (usually located in middle mediastinum)•Pericardial cyst

### Superior mediastinal mass {#s2830}

Descending through thoracic inlet•Thyroid masses•Adenopathy (primary head and neck tumors)•Lymphatic cysts, cystic hygromaAscending through thoracic inlet•Small cell carcinoma of the lungLymphomaAneurysm and vascular anomalies may involve both the anterior and superior mediastinal compartments.

### Middle mediastinal mass {#s2835}

Adenopathy (often bilateral)•Benign: sarcoid, TB, fungal infection, chronic beryllium exposure•Malignant: metastases, lymphoma, leukemiaCongenital cysts•Bronchogenic cysts (subcarinal, anterior trachea)•Pericardial cystsAneurysm•Aorta, aortic branches•Pulmonary arteryEsophagus•Hiatal hernia (common)•Neoplasm•Diverticula•Megaesophagus: achalasia, hiatal hernia, colonic interpositionOther•Mediastinal hemorrhage•Mediastinal lipomatosis•Bronchogenic cancer arising adjacent to mediastinum•Aberrant RSA with diverticulum•Varices•Neurinoma from recurrent laryngeal nerve•Malignancy of trachea•Pancreatic pseudocyst

### Adenopathy {#s2840}

Low-attenuation lymph nodes•TB and fungal infections in AIDS (ring enhancement)•Necrotic metastases (aggressive neoplasm)•Lymphoma (occasionally)Vascularized lymph nodes•Castleman disease (giant benign nodal hyperplasia)•Vascular metastases: renal cell, thyroid, small cell, melanomaCalcified lymph nodes•TB•Histoplasmosis, other fungus•Sarcoidosis•Silicosis•Radiation therapy

### Posterior mediastinal mass ([Fig. 1-97](#f0490){ref-type="fig"}) {#s2845}

Neurogenic, 90%•Peripheral nerves (20 to 40 years; \<2 vertebral bodies long): schwannoma and neurofibroma, 45%•Sympathetic ganglia (\<20 years; \>2 vertebral bodies long): ganglioneuroma, neuroblastoma, sympathicoblastoma•Paraganglionic cells: pheochromocytoma, paraganglioma (least common)•Lateral meningomyeloceleThoracic spine•Neoplasm•Hematoma•Extramedullary hematopoiesis (bilateral)•DiskitisVascular•Aneurysm•Azygos continuation (congenital absence of IVC with dilated azygos and hemiazygos veins) Figure 1-97

### Cardiophrenic angle mass {#s2850}

•Fat pad (most common cause)•Diaphragmatic hernia (second most common)Morgagni (anterior; 90% on right side)Bochdalek (posterior; more common on left; not a true cardiophrenic mass)•Pericardial cyst•Cardiophrenic angle nodes (lymphoma usually recurrent, status postradiation)•Aneurysm•Dilated right atrium•Anterior mediastinal mass•Primary lung or pleural mass

### Fatty mediastinal lesions {#s2855}

Purely fatty lesions•Mediastinal lipomatosis•Morgagni hernia (omentum)•Bochdalek hernia (omentum)•Periesophageal fat herniationTumors with fatty components•Lipoma•Liposarcoma•Thymolipoma (children and young adults, lesions are usually very large)•Germ cell tumors (also contain calcifications and cystic and solid regions)

### High-density mediastinal lesions (noncontrast CT) {#s2860}

Calcified lymph nodesCalcified primary mass•Tumor•Goiter•AneurysmHemorrhage

### Densely enhancing mediastinal mass {#s2865}

Vascular•Aneurysm•Vascular abnormalities•Esophageal varicesHypervascular tumors: paraganglioma, metastasis from thyroid cancer, RCCGoiterCastleman disease

### Retrocrural adenopathy {#s2870}

Inflammation•Sarcoidosis•LAM•AmyloidosisInfection•AIDS•TB•*M. avium*LymphomaMets

### Prominent hila ([Fig. 1-98](#f0495){ref-type="fig"}) {#s2875}

Tumors•Central bronchogenic carcinoma•LymphomaAdenopathy•Infectious: TB, fungi, histoplasmosis•Inflammatory: sarcoid, silicosis•Tumor: commonly oat cell, lymphoma, metastasesPulmonary artery enlargement Figure 1-98

### Eggshell calcification in hilar nodes {#s2880}

•Silicosis, CWP•Treated lymphoma•Granulomatous disease such as histoplasmosis rarely contains eggshell calcification; diffuse calcifications are more common.•Sarcoid (rare and late in disease)

### Pneumomediastinum {#s2885}

Pulmonary•Asthma (common)•Barotrauma (intubation, diver)•Childbirth•PneumothoraxMediastinum•Tracheobronchial laceration•Esophageal perforation•Mediastinal surgery•Boerhaave syndromeAbdomen•Intraperitoneal or retroperitoneal bowel perforation•Retroperitoneal surgeryHead and neck•Esophageal rupture•Facial fractures•Dental or retropharyngeal infection, mediastinitis

These nodes are best assessed by mediastinoscopy; the remainder of nodes are best assessed by CT.

[^1]: Rarely present as a resectable T1 lesion.

[^2]: FDG, Fluorodeoxyglucose; HPF, High-Power Field; LCNEC, Large Cell Neuroendocrine Carcinoma; SCLC, Small Cell Lung Cancer.

[^3]: AIP, Acute Interstitial Pneumonia; CHP, Chronic Hypersensitivity Pneumonitis; COP, Cryptogenic Organizing Pneumonia; DIP, Desquamative Interstitial Pneumonitis; IPF, Idiopathic Pulmonary Fibrosis; LIP, Lymphoid Interstitial Pneumonia; NSIP, Nonspecific Interstitial Pneumonia; RB-ILD, Respiratory Bronchiolitis-Associated Interstitial Lung Disease; UIP, Usual Interstitial Pneumonia.

[^4]: The designations "lobular" and "acinai" refer to the number of acini affected (a few acini make up a lobule).

[^5]: Normal tracheobronchial tree has 23 to 24 divisions.

[^6]: Constitutional symptoms (classification B) are present in 25%: fever, night sweats, weight loss.

[^7]: Constitutional symptoms are more common than in Hodgkin disease.
